-
1
-
-
70350031257
-
Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children
-
Abdulla S., Sagara I. Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children. Malar. J. 2009, 8(Suppl. 1):S7.
-
(2009)
Malar. J.
, vol.8
, Issue.SUPPL. 1
-
-
Abdulla, S.1
Sagara, I.2
-
2
-
-
85040956318
-
Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS, S/AS02D malaria vaccine in infants living in a malaria-endemic region
-
Abdulla S., Salim N., Machera F., Kamata R., Juma O., Shomari M., Kubhoja S., Mohammed A., Mwangoka G., Aebi T., Mshinda H., Schellenberg D., Carter T., Villafana T., Dubois M.C., Leach A., Lievens M., Vekemans J., Cohen J., Ballou W.R., Tanner M. Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS, S/AS02D malaria vaccine in infants living in a malaria-endemic region. Malar. J. 2013, 12:11.
-
(2013)
Malar. J.
, vol.12
, pp. 11
-
-
Abdulla, S.1
Salim, N.2
Machera, F.3
Kamata, R.4
Juma, O.5
Shomari, M.6
Kubhoja, S.7
Mohammed, A.8
Mwangoka, G.9
Aebi, T.10
Mshinda, H.11
Schellenberg, D.12
Carter, T.13
Villafana, T.14
Dubois, M.C.15
Leach, A.16
Lievens, M.17
Vekemans, J.18
Cohen, J.19
Ballou, W.R.20
Tanner, M.21
more..
-
3
-
-
0022499206
-
Phase II trials of alpha-difluoromethylornithine, an inhibitor of polyamine synthesis, in advanced small cell lung cancer and colon cancer
-
Abeloff M.D., Rosen S.T., Luk G.D., Baylin S.B., Zeltzman M., Sjoerdsma A. Phase II trials of alpha-difluoromethylornithine, an inhibitor of polyamine synthesis, in advanced small cell lung cancer and colon cancer. Cancer Treat. Rep. 1986, 70(7):843-845.
-
(1986)
Cancer Treat. Rep.
, vol.70
, Issue.7
, pp. 843-845
-
-
Abeloff, M.D.1
Rosen, S.T.2
Luk, G.D.3
Baylin, S.B.4
Zeltzman, M.5
Sjoerdsma, A.6
-
4
-
-
33947263004
-
Prevention and treatment of cryptosporidiosis in immunocompromised patients
-
Abubakar I., Aliyu S.H., Arumugam C., Hunter P.R., Usman N.K. Prevention and treatment of cryptosporidiosis in immunocompromised patients. Cochrane Database Syst. Rev. 2007, 1:CD004932.
-
(2007)
Cochrane Database Syst. Rev.
, vol.1
-
-
Abubakar, I.1
Aliyu, S.H.2
Arumugam, C.3
Hunter, P.R.4
Usman, N.K.5
-
5
-
-
79956282726
-
Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria
-
Achan J., Talisuna A.O., Erhart A., Yeka A., Tibenderana J.K., Baliraine F.N., Rosenthal P.J., D'Alessandro U. Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar. J. 2011, 10:144.
-
(2011)
Malar. J.
, vol.10
, pp. 144
-
-
Achan, J.1
Talisuna, A.O.2
Erhart, A.3
Yeka, A.4
Tibenderana, J.K.5
Baliraine, F.N.6
Rosenthal, P.J.7
D'Alessandro, U.8
-
6
-
-
81455154875
-
First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children
-
Agnandji S.T., Lell B., Soulanoudjingar S.S., Fernandes J.F., Abossolo B.P., Conzelmann C., Methogo B.G., Doucka Y., Flamen A., Mordmuller B., Issifou S., Kremsner P.G., Sacarlal J., Aide P., Lanaspa M., Aponte J.J., Nhamuave A., Quelhas D., Bassat Q., Mandjate S., Macete E., Alonso P., Abdulla S., Salim N., Juma O., Shomari M., Shubis K., Machera F., Hamad A.S., Minja R., Mtoro A., Sykes A., Ahmed S., Urassa A.M., Ali A.M., Mwangoka G., Tanner M., Tinto H., D'Alessandro U., Sorgho H., Valea I., Tahita M.C., Kabore W., Ouedraogo S., Sandrine Y., Guiguemde R.T., Ouedraogo J.B., Hamel M.J., Kariuki S., Odero C., Oneko M., Otieno K., Awino N., Omoto J., Williamson J., Muturi-Kioi V., Laserson K.F., Slutsker L., Otieno W., Otieno L., Nekoye O., Gondi S., Otieno A., Ogutu B., Wasuna R., Owira V., Jones D., Onyango A.A., Njuguna P., Chilengi R., Akoo P., Kerubo C., Gitaka J., Maingi C., Lang T., Olotu A., Tsofa B., Bejon P., Peshu N., Marsh K., Owusu-Agyei S., Asante K.P., Osei-Kwakye K., Boahen O., Ayamba S., Kayan K., Owusu-Ofori R., Dosoo D., Asante I., Adjei G., Chandramohan D., Greenwood B., Lusingu J., Gesase S., Malabeja A., Abdul O., Kilavo H., Mahende C., Liheluka E., Lemnge M., Theander T., Drakeley C., Ansong D., Agbenyega T., Adjei S., Boateng H.O., Rettig T., Bawa J., Sylverken J., Sambian D., Agyekum A., Owusu L., Martinson F., Hoffman I., Mvalo T., Kamthunzi P., Nkomo R., Msika A., Jumbe A., Chome N., Nyakuipa D., Chintedza J., Ballou W.R., Bruls M., Cohen J., Guerra Y., Jongert E., Lapierre D., Leach A., Lievens M., Ofori-Anyinam O., Vekemans J., Carter T., Leboulleux D., Loucq C., Radford A., Savarese B., Schellenberg D., Sillman M., Vansadia P. First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children. N. Engl. J. Med. 2011, 365(20):1863-1875.
-
(2011)
N. Engl. J. Med.
, vol.365
, Issue.20
, pp. 1863-1875
-
-
Agnandji, S.T.1
Lell, B.2
Soulanoudjingar, S.S.3
Fernandes, J.F.4
Abossolo, B.P.5
Conzelmann, C.6
Methogo, B.G.7
Doucka, Y.8
Flamen, A.9
Mordmuller, B.10
Issifou, S.11
Kremsner, P.G.12
Sacarlal, J.13
Aide, P.14
Lanaspa, M.15
Aponte, J.J.16
Nhamuave, A.17
Quelhas, D.18
Bassat, Q.19
Mandjate, S.20
Macete, E.21
Alonso, P.22
Abdulla, S.23
Salim, N.24
Juma, O.25
Shomari, M.26
Shubis, K.27
Machera, F.28
Hamad, A.S.29
Minja, R.30
Mtoro, A.31
Sykes, A.32
Ahmed, S.33
Urassa, A.M.34
Ali, A.M.35
Mwangoka, G.36
Tanner, M.37
Tinto, H.38
D'Alessandro, U.39
Sorgho, H.40
Valea, I.41
Tahita, M.C.42
Kabore, W.43
Ouedraogo, S.44
Sandrine, Y.45
Guiguemde, R.T.46
Ouedraogo, J.B.47
Hamel, M.J.48
Kariuki, S.49
Odero, C.50
Oneko, M.51
Otieno, K.52
Awino, N.53
Omoto, J.54
Williamson, J.55
Muturi-Kioi, V.56
Laserson, K.F.57
Slutsker, L.58
Otieno, W.59
Otieno, L.60
Nekoye, O.61
Gondi, S.62
Otieno, A.63
Ogutu, B.64
Wasuna, R.65
Owira, V.66
Jones, D.67
Onyango, A.A.68
Njuguna, P.69
Chilengi, R.70
Akoo, P.71
Kerubo, C.72
Gitaka, J.73
Maingi, C.74
Lang, T.75
Olotu, A.76
Tsofa, B.77
Bejon, P.78
Peshu, N.79
Marsh, K.80
Owusu-Agyei, S.81
Asante, K.P.82
Osei-Kwakye, K.83
Boahen, O.84
Ayamba, S.85
Kayan, K.86
Owusu-Ofori, R.87
Dosoo, D.88
Asante, I.89
Adjei, G.90
Chandramohan, D.91
Greenwood, B.92
Lusingu, J.93
Gesase, S.94
Malabeja, A.95
Abdul, O.96
Kilavo, H.97
Mahende, C.98
Liheluka, E.99
more..
-
7
-
-
73149102077
-
High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial
-
Amadi B., Mwiya M., Sianongo S., Payne L., Watuka A., Katubulushi M., Kelly P. High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial. BMC Infect. Dis. 2009, 9:195.
-
(2009)
BMC Infect. Dis.
, vol.9
, pp. 195
-
-
Amadi, B.1
Mwiya, M.2
Sianongo, S.3
Payne, L.4
Watuka, A.5
Katubulushi, M.6
Kelly, P.7
-
8
-
-
79951847989
-
Principles and current strategies for targeting autophagy for cancer treatment
-
Amaravadi R.K., Lippincott-Schwartz J., Yin X.M., Weiss W.A., Takebe N., Timmer W., DiPaola R.S., Lotze M.T., White E. Principles and current strategies for targeting autophagy for cancer treatment. Clin. Cancer Res. 2011, 17(4):654-666.
-
(2011)
Clin. Cancer Res.
, vol.17
, Issue.4
, pp. 654-666
-
-
Amaravadi, R.K.1
Lippincott-Schwartz, J.2
Yin, X.M.3
Weiss, W.A.4
Takebe, N.5
Timmer, W.6
DiPaola, R.S.7
Lotze, M.T.8
White, E.9
-
10
-
-
84867532069
-
Towards histone deacetylase inhibitors as new antimalarial drugs
-
Andrews K.T., Tran T.N., Fairlie D.P. Towards histone deacetylase inhibitors as new antimalarial drugs. Curr. Pharm. Des. 2012, 18(24):3467-3479.
-
(2012)
Curr. Pharm. Des.
, vol.18
, Issue.24
, pp. 3467-3479
-
-
Andrews, K.T.1
Tran, T.N.2
Fairlie, D.P.3
-
11
-
-
84885951127
-
Antimalarial activity of compounds comprising a primary benzene sulfonamide fragment
-
Andrews K.T., Fisher G.M., Sumanadasa S.D., Skinner-Adams T., Moeker J., Lopez M., Poulsen S.A. Antimalarial activity of compounds comprising a primary benzene sulfonamide fragment. Bioorg. Med. Chem. Lett. 2013, 23(22):6114-6117.
-
(2013)
Bioorg. Med. Chem. Lett.
, vol.23
, Issue.22
, pp. 6114-6117
-
-
Andrews, K.T.1
Fisher, G.M.2
Sumanadasa, S.D.3
Skinner-Adams, T.4
Moeker, J.5
Lopez, M.6
Poulsen, S.A.7
-
12
-
-
84865832714
-
The global pipeline of new medicines for the control and elimination of malaria
-
Anthony M.P., Burrows J.N., Duparc S., Moehrle J.J., Wells T.N. The global pipeline of new medicines for the control and elimination of malaria. Malar. J. 2012, 11:316.
-
(2012)
Malar. J.
, vol.11
, pp. 316
-
-
Anthony, M.P.1
Burrows, J.N.2
Duparc, S.3
Moehrle, J.J.4
Wells, T.N.5
-
13
-
-
0026073466
-
Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii
-
Araujo F.G., Huskinson J., Remington J.S. Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii. Antimicrob. Agents Chemother. 1991, 35(2):293-299.
-
(1991)
Antimicrob. Agents Chemother.
, vol.35
, Issue.2
, pp. 293-299
-
-
Araujo, F.G.1
Huskinson, J.2
Remington, J.S.3
-
14
-
-
84892372929
-
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
-
Ariey F., Witkowski B., Amaratunga C., Beghain J., Langlois A.C., Khim N., Kim S., Duru V., Bouchier C., Ma L., Lim P., Leang R., Duong S., Sreng S., Suon S., Chuor C.M., Bout D.M., Menard S., Rogers W.O., Genton B., Fandeur T., Miotto O., Ringwald P., Le Bras J., Berry A., Barale J.C., Fairhurst R.M., Benoit-Vical F., Mercereau-Puijalon O., Menard D. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 2014, 505(7481):50-55.
-
(2014)
Nature
, vol.505
, Issue.7481
, pp. 50-55
-
-
Ariey, F.1
Witkowski, B.2
Amaratunga, C.3
Beghain, J.4
Langlois, A.C.5
Khim, N.6
Kim, S.7
Duru, V.8
Bouchier, C.9
Ma, L.10
Lim, P.11
Leang, R.12
Duong, S.13
Sreng, S.14
Suon, S.15
Chuor, C.M.16
Bout, D.M.17
Menard, S.18
Rogers, W.O.19
Genton, B.20
Fandeur, T.21
Miotto, O.22
Ringwald, P.23
Le Bras, J.24
Berry, A.25
Barale, J.C.26
Fairhurst, R.M.27
Benoit-Vical, F.28
Mercereau-Puijalon, O.29
Menard, D.30
more..
-
15
-
-
4344668661
-
Drug repositioning: identifying and developing new uses for existing drugs
-
Ashburn T.T., Thor K.B. Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Disc. 2004, 3(8):673-683.
-
(2004)
Nat Rev Drug Disc.
, vol.3
, Issue.8
, pp. 673-683
-
-
Ashburn, T.T.1
Thor, K.B.2
-
17
-
-
84874237745
-
Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story
-
Baker N., de Koning H.P., Maser P., Horn D. Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story. Trends Parasitol. 2013, 29(3):110-118.
-
(2013)
Trends Parasitol.
, vol.29
, Issue.3
, pp. 110-118
-
-
Baker, N.1
de Koning, H.P.2
Maser, P.3
Horn, D.4
-
18
-
-
0032795221
-
Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis
-
Baltzan M., Mehta S., Kirkham T.H., Cosio M.G. Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 1999, 160(1):192-197.
-
(1999)
Am. J. Respir. Crit. Care Med.
, vol.160
, Issue.1
, pp. 192-197
-
-
Baltzan, M.1
Mehta, S.2
Kirkham, T.H.3
Cosio, M.G.4
-
19
-
-
0032772139
-
Risk factors for Toxoplasma infection in pregnancy: a case-control study in France
-
Baril L., Ancelle T., Goulet V., Thulliez P., Tirard-Fleury V., Carme B. Risk factors for Toxoplasma infection in pregnancy: a case-control study in France. Scand. J. Infect. Dis. 1999, 31(3):305-309.
-
(1999)
Scand. J. Infect. Dis.
, vol.31
, Issue.3
, pp. 305-309
-
-
Baril, L.1
Ancelle, T.2
Goulet, V.3
Thulliez, P.4
Tirard-Fleury, V.5
Carme, B.6
-
20
-
-
80053517353
-
Drug resistance in human African trypanosomiasis
-
Barrett M.P., Vincent I.M., Burchmore R.J., Kazibwe A.J., Matovu E. Drug resistance in human African trypanosomiasis. Future Microbiol. 2011, 6(9):1037-1047.
-
(2011)
Future Microbiol.
, vol.6
, Issue.9
, pp. 1037-1047
-
-
Barrett, M.P.1
Vincent, I.M.2
Burchmore, R.J.3
Kazibwe, A.J.4
Matovu, E.5
-
21
-
-
36949016420
-
Cinchonism in a patient taking Quinine for leg cramps
-
Barrocas A.M., Cymet T. Cinchonism in a patient taking Quinine for leg cramps. Compr. Ther. 2007, 33(3):162-163.
-
(2007)
Compr. Ther.
, vol.33
, Issue.3
, pp. 162-163
-
-
Barrocas, A.M.1
Cymet, T.2
-
23
-
-
84867513471
-
Protein kinases as potential targets for novel anti-schistosomal strategies
-
Beckmann S., Leutner S., Gouignard N., Dissous C., Grevelding C.G. Protein kinases as potential targets for novel anti-schistosomal strategies. Curr. Pharm. Des. 2012, 18(24):3579-3594.
-
(2012)
Curr. Pharm. Des.
, vol.18
, Issue.24
, pp. 3579-3594
-
-
Beckmann, S.1
Leutner, S.2
Gouignard, N.3
Dissous, C.4
Grevelding, C.G.5
-
24
-
-
84873494490
-
Topical paromomycin with or without gentamicin for cutaneous leishmaniasis
-
Ben Salah A., Ben Messaoud N., Guedri E., Zaatour A., Ben Alaya N., Bettaieb J., Gharbi A., Belhadj Hamida N., Boukthir A., Chlif S., Abdelhamid K., El Ahmadi Z., Louzir H., Mokni M., Morizot G., Buffet P., Smith P.L., Kopydlowski K.M., Kreishman-Deitrick M., Smith K.S., Nielsen C.J., Ullman D.R., Norwood J.A., Thorne G.D., McCarthy W.F., Adams R.C., Rice R.M., Tang D., Berman J., Ransom J., Magill A.J., Grogl M. Topical paromomycin with or without gentamicin for cutaneous leishmaniasis. N. Engl. J. Med. 2013, 368(6):524-532.
-
(2013)
N. Engl. J. Med.
, vol.368
, Issue.6
, pp. 524-532
-
-
Ben Salah, A.1
Ben Messaoud, N.2
Guedri, E.3
Zaatour, A.4
Ben Alaya, N.5
Bettaieb, J.6
Gharbi, A.7
Belhadj Hamida, N.8
Boukthir, A.9
Chlif, S.10
Abdelhamid, K.11
El Ahmadi, Z.12
Louzir, H.13
Mokni, M.14
Morizot, G.15
Buffet, P.16
Smith, P.L.17
Kopydlowski, K.M.18
Kreishman-Deitrick, M.19
Smith, K.S.20
Nielsen, C.J.21
Ullman, D.R.22
Norwood, J.A.23
Thorne, G.D.24
McCarthy, W.F.25
Adams, R.C.26
Rice, R.M.27
Tang, D.28
Berman, J.29
Ransom, J.30
Magill, A.J.31
Grogl, M.32
more..
-
25
-
-
84891762026
-
The ChEMBL bioactivity database: an update
-
Bento A.P., Gaulton A., Hersey A., Bellis L.J., Chambers J., Davies M., Kruger F.A., Light Y., Mak L., McGlinchey S., Nowotka M., Papadatos G., Santos R., Overington J.P. The ChEMBL bioactivity database: an update. Nucleic Acids Res. 2014, 42(1):D1083-D1090.
-
(2014)
Nucleic Acids Res.
, vol.42
, Issue.1
-
-
Bento, A.P.1
Gaulton, A.2
Hersey, A.3
Bellis, L.J.4
Chambers, J.5
Davies, M.6
Kruger, F.A.7
Light, Y.8
Mak, L.9
McGlinchey, S.10
Nowotka, M.11
Papadatos, G.12
Santos, R.13
Overington, J.P.14
-
26
-
-
84862226725
-
Hydroxychloroquine: from malaria to autoimmunity
-
Ben-Zvi I., Kivity S., Langevitz P., Shoenfeld Y. Hydroxychloroquine: from malaria to autoimmunity. Clin. Rev. Allergy Immunol. 2012, 42(2):145-153.
-
(2012)
Clin. Rev. Allergy Immunol.
, vol.42
, Issue.2
, pp. 145-153
-
-
Ben-Zvi, I.1
Kivity, S.2
Langevitz, P.3
Shoenfeld, Y.4
-
27
-
-
52649153653
-
Treatment of leishmaniasis with miltefosine: 2008 status
-
Berman J.J. Treatment of leishmaniasis with miltefosine: 2008 status. Expert Opin. Drug Metab. Toxicol. 2008, 4(9):1209-1216.
-
(2008)
Expert Opin. Drug Metab. Toxicol.
, vol.4
, Issue.9
, pp. 1209-1216
-
-
Berman, J.J.1
-
28
-
-
17544387144
-
Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries
-
Berman J.D., Badaro R., Thakur C.P., Wasunna K.M., Behbehani K., Davidson R., Kuzoe F., Pang L., Weerasuriya K., Bryceson A.D. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries. Bull. World Health Organ. 1998, 76(1):25-32.
-
(1998)
Bull. World Health Organ.
, vol.76
, Issue.1
, pp. 25-32
-
-
Berman, J.D.1
Badaro, R.2
Thakur, C.P.3
Wasunna, K.M.4
Behbehani, K.5
Davidson, R.6
Kuzoe, F.7
Pang, L.8
Weerasuriya, K.9
Bryceson, A.D.10
-
29
-
-
34548702901
-
Melarsoprol- and pentamidine-resistant Trypanosoma brucei rhodesiense populations and their cross-resistance
-
Bernhard S.C., Nerima B., Maser P., Brun R. Melarsoprol- and pentamidine-resistant Trypanosoma brucei rhodesiense populations and their cross-resistance. Int. J. Parasitol. 2007, 37(13):1443-1448.
-
(2007)
Int. J. Parasitol.
, vol.37
, Issue.13
, pp. 1443-1448
-
-
Bernhard, S.C.1
Nerima, B.2
Maser, P.3
Brun, R.4
-
30
-
-
84875197025
-
Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth
-
Bessoff K., Sateriale A., Lee K.K., Huston C.D. Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth. Antimicrob. Agents Chemother. 2013, 57(4):1804-1814.
-
(2013)
Antimicrob. Agents Chemother.
, vol.57
, Issue.4
, pp. 1804-1814
-
-
Bessoff, K.1
Sateriale, A.2
Lee, K.K.3
Huston, C.D.4
-
31
-
-
0029061493
-
Lupus anticoagulant in the elderly may be associated with both quinine and quinidine usage
-
Bird M.R., O'Neill A.I., Buchanan R.R., Ibrahim K.M., Des Parkin J. Lupus anticoagulant in the elderly may be associated with both quinine and quinidine usage. Pathology 1995, 27(2):136-139.
-
(1995)
Pathology
, vol.27
, Issue.2
, pp. 136-139
-
-
Bird, M.R.1
O'Neill, A.I.2
Buchanan, R.R.3
Ibrahim, K.M.4
Des Parkin, J.5
-
32
-
-
82555165572
-
Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness
-
Bland N.D., Wang C., Tallman C., Gustafson A.E., Wang Z., Ashton T.D., Ochiana S.O., McAllister G., Cotter K., Fang A.P., Gechijian L., Garceau N., Gangurde R., Ortenberg R., Ondrechen M.J., Campbell R.K., Pollastri M.P. Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness. J. Med. Chem. 2011, 54(23):8188-8194.
-
(2011)
J. Med. Chem.
, vol.54
, Issue.23
, pp. 8188-8194
-
-
Bland, N.D.1
Wang, C.2
Tallman, C.3
Gustafson, A.E.4
Wang, Z.5
Ashton, T.D.6
Ochiana, S.O.7
McAllister, G.8
Cotter, K.9
Fang, A.P.10
Gechijian, L.11
Garceau, N.12
Gangurde, R.13
Ortenberg, R.14
Ondrechen, M.J.15
Campbell, R.K.16
Pollastri, M.P.17
-
33
-
-
54949108677
-
PubChem: integrated platform of small molecules and biological activities
-
(Chapter 12)
-
Bolton E., Wang Y., Thiessen P.A., Bryant S.H. PubChem: integrated platform of small molecules and biological activities. Annu. Rep. Comput. Chem. 2008, 4. (Chapter 12).
-
(2008)
Annu. Rep. Comput. Chem.
, vol.4
-
-
Bolton, E.1
Wang, Y.2
Thiessen, P.A.3
Bryant, S.H.4
-
34
-
-
84967961893
-
-
British Medical Journal Sulphadiazine
-
British Medical Journal Sulphadiazine. Br. Med. J. 1942, 1(4228):76-77.
-
(1942)
Br. Med. J.
, vol.1
, Issue.4228
, pp. 76-77
-
-
-
35
-
-
84897997986
-
TOXOPLASMIC uveitis and pyrimethamine (author not listed)
-
British Medical Journal
-
British Medical Journal TOXOPLASMIC uveitis and pyrimethamine (author not listed). Br. Med. J. 1957, 2(5052):1042-1044.
-
(1957)
Br. Med. J.
, vol.2
, Issue.5052
, pp. 1042-1044
-
-
-
36
-
-
49049097255
-
Development and in vitro evaluation of chloroquine gels as microbicides against HIV-1 infection
-
Brouwers J., Vermeire K., Schols D., Augustijns P. Development and in vitro evaluation of chloroquine gels as microbicides against HIV-1 infection. Virology 2008, 378(2):306-310.
-
(2008)
Virology
, vol.378
, Issue.2
, pp. 306-310
-
-
Brouwers, J.1
Vermeire, K.2
Schols, D.3
Augustijns, P.4
-
37
-
-
0034777039
-
The phenomenon of treatment failures in Human African Trypanosomiasis
-
Brun R., Schumacher R., Schmid C., Kunz C., Burri C. The phenomenon of treatment failures in Human African Trypanosomiasis. Trop. Med. Int. Health 2001, 6(11):906-914.
-
(2001)
Trop. Med. Int. Health
, vol.6
, Issue.11
, pp. 906-914
-
-
Brun, R.1
Schumacher, R.2
Schmid, C.3
Kunz, C.4
Burri, C.5
-
38
-
-
79959790904
-
Development of novel drugs for human African trypanosomiasis
-
Brun R., Don R., Jacobs R.T., Wang M.Z., Barrett M.P. Development of novel drugs for human African trypanosomiasis. Future Microbiol. 2011, 6(6):677-691.
-
(2011)
Future Microbiol.
, vol.6
, Issue.6
, pp. 677-691
-
-
Brun, R.1
Don, R.2
Jacobs, R.T.3
Wang, M.Z.4
Barrett, M.P.5
-
39
-
-
0038639784
-
Eflornithine for the treatment of human African trypanosomiasis
-
Burri C., Brun R. Eflornithine for the treatment of human African trypanosomiasis. Parasitol. Res. 2003, 90(Supp 1):S49-S52.
-
(2003)
Parasitol. Res.
, vol.90
, Issue.SUPPL. 1
-
-
Burri, C.1
Brun, R.2
-
40
-
-
0034991804
-
Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment
-
Burri C., Keiser J. Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment. Trop. Med. Int. Health 2001, 6(5):412-420.
-
(2001)
Trop. Med. Int. Health
, vol.6
, Issue.5
, pp. 412-420
-
-
Burri, C.1
Keiser, J.2
-
41
-
-
84878506144
-
Designing the next generation of medicines for malaria control and eradication
-
Burrows J.N., van Huijsduijnen R.H., Mohrle J.J., Oeuvray C., Wells T.N. Designing the next generation of medicines for malaria control and eradication. Malar. J. 2013, 12:187.
-
(2013)
Malar. J.
, vol.12
, pp. 187
-
-
Burrows, J.N.1
van Huijsduijnen, R.H.2
Mohrle, J.J.3
Oeuvray, C.4
Wells, T.N.5
-
42
-
-
63449120111
-
Mebendazole in parasitic infections other than those caused by soil-transmitted helminths
-
Canete R., Escobedo A.A., Almirall P., Gonzalez M.E., Brito K., Cimerman S. Mebendazole in parasitic infections other than those caused by soil-transmitted helminths. Trans. R. Soc. Trop. Med. Hyg. 2009, 103(5):437-442.
-
(2009)
Trans. R. Soc. Trop. Med. Hyg.
, vol.103
, Issue.5
, pp. 437-442
-
-
Canete, R.1
Escobedo, A.A.2
Almirall, P.3
Gonzalez, M.E.4
Brito, K.5
Cimerman, S.6
-
43
-
-
68549101792
-
Recent advances in the development of polyamine analogues as antitumor agents
-
Casero R.A., Woster P.M. Recent advances in the development of polyamine analogues as antitumor agents. J. Med. Chem. 2009, 52(15):4551-4573.
-
(2009)
J. Med. Chem.
, vol.52
, Issue.15
, pp. 4551-4573
-
-
Casero, R.A.1
Woster, P.M.2
-
44
-
-
79952967329
-
Drug discovery and development for neglected diseases: the DNDi model
-
Chatelain E., Ioset J.R. Drug discovery and development for neglected diseases: the DNDi model. Drug Des. Dev. Ther. 2011, 5:175-181.
-
(2011)
Drug Des. Dev. Ther.
, vol.5
, pp. 175-181
-
-
Chatelain, E.1
Ioset, J.R.2
-
45
-
-
40349116310
-
Estimates of the duration of the early and late stage of gambiense sleeping sickness
-
Checchi F., Filipe J.A., Haydon D.T., Chandramohan D., Chappuis F. Estimates of the duration of the early and late stage of gambiense sleeping sickness. BMC Infect. Dis. 2008, 8:16.
-
(2008)
BMC Infect. Dis.
, vol.8
, pp. 16
-
-
Checchi, F.1
Filipe, J.A.2
Haydon, D.T.3
Chandramohan, D.4
Chappuis, F.5
-
46
-
-
0037198443
-
-
Cryptosporidiosis
-
Chen X.M., Keithly J.S., Paya C.V., LaRusso N.F. Cryptosporidiosis. N. Engl. J. Med. 2002, 346(22):1723-1731.
-
(2002)
N. Engl. J. Med.
, vol.346
, Issue.22
, pp. 1723-1731
-
-
Chen, X.M.1
Keithly, J.S.2
Paya, C.V.3
LaRusso, N.F.4
-
47
-
-
33746381549
-
A clinical drug library screen identifies astemizole as an antimalarial agent
-
Chong C.R., Chen X., Shi L., Liu J.O., Sullivan D.J. A clinical drug library screen identifies astemizole as an antimalarial agent. Nat. Chem. Biol. 2006, 2(8):415-416.
-
(2006)
Nat. Chem. Biol.
, vol.2
, Issue.8
, pp. 415-416
-
-
Chong, C.R.1
Chen, X.2
Shi, L.3
Liu, J.O.4
Sullivan, D.J.5
-
48
-
-
0016755327
-
Clindamycin vs placebo as adjunctive therapy in moderately severe acne
-
Christian G.L., Krueger G.G. Clindamycin vs placebo as adjunctive therapy in moderately severe acne. Arch. Dermatol. 1975, 111(8):997-1000.
-
(1975)
Arch. Dermatol.
, vol.111
, Issue.8
, pp. 997-1000
-
-
Christian, G.L.1
Krueger, G.G.2
-
49
-
-
0015146873
-
Antimalarial effects of tetracyclines in man
-
Clyde D.F., Miller R.M., DuPont H.L., Hornick R.B. Antimalarial effects of tetracyclines in man. J. Trop. Med. Hyg. 1971, 74(11):238-242.
-
(1971)
J. Trop. Med. Hyg.
, vol.74
, Issue.11
, pp. 238-242
-
-
Clyde, D.F.1
Miller, R.M.2
DuPont, H.L.3
Hornick, R.B.4
-
50
-
-
0016812414
-
Comparison of metronidazole and chloroquine for the treatment of amoebic liver abscess
-
Cohen H.G., Reynolds T.B. Comparison of metronidazole and chloroquine for the treatment of amoebic liver abscess. Control. Trial Gastroenterol. 1975, 69(1):35-41.
-
(1975)
Control. Trial Gastroenterol.
, vol.69
, Issue.1
, pp. 35-41
-
-
Cohen, H.G.1
Reynolds, T.B.2
-
51
-
-
85015295681
-
The local treatment of burns with sulfadiazine spray
-
Coloviras G.J., West W.T., Armour J.C. The local treatment of burns with sulfadiazine spray. Can. Med. Assoc. J. 1942, 47(6):505-514.
-
(1942)
Can. Med. Assoc. J.
, vol.47
, Issue.6
, pp. 505-514
-
-
Coloviras, G.J.1
West, W.T.2
Armour, J.C.3
-
52
-
-
0034661807
-
Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European research network on congenital toxoplasmosis
-
Cook A.J., Gilbert R.E., Buffolano W., Zufferey J., Petersen E., Jenum P.A., Foulon W., Semprini A.E., Dunn D.T. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European research network on congenital toxoplasmosis. BMJ 2000, 321(7254):142-147.
-
(2000)
BMJ
, vol.321
, Issue.7254
, pp. 142-147
-
-
Cook, A.J.1
Gilbert, R.E.2
Buffolano, W.3
Zufferey, J.4
Petersen, E.5
Jenum, P.A.6
Foulon, W.7
Semprini, A.E.8
Dunn, D.T.9
-
53
-
-
77954187759
-
Chagas disease: a new worldwide challenge
-
Coura J.R., Vinas P.A. Chagas disease: a new worldwide challenge. Nature 2010, 465(7301):S6-S7.
-
(2010)
Nature
, vol.465
, Issue.7301
-
-
Coura, J.R.1
Vinas, P.A.2
-
54
-
-
0030961481
-
Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission. I. Preliminary evaluation
-
Coura J.R., de Abreu L.L., Willcox H.P., Petana W. Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission. I. Preliminary evaluation. Rev. Soc. Bras. Med. Trop. 1997, 30(2):139-144.
-
(1997)
Rev. Soc. Bras. Med. Trop.
, vol.30
, Issue.2
, pp. 139-144
-
-
Coura, J.R.1
de Abreu, L.L.2
Willcox, H.P.3
Petana, W.4
-
55
-
-
0023809380
-
Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection
-
Couvreur J., Desmonts G., Thulliez P. Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection. J. Antimicrob. Chemother. 1988, 22(Suppl. B):193-200.
-
(1988)
J. Antimicrob. Chemother.
, vol.22
, Issue.SUPPL. B
, pp. 193-200
-
-
Couvreur, J.1
Desmonts, G.2
Thulliez, P.3
-
56
-
-
0142258171
-
Leishmaniasis - current chemotherapy and recent advances in the search for novel drugs
-
Croft S.L., Coombs G.H. Leishmaniasis - current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol. 2003, 19(11):502-508.
-
(2003)
Trends Parasitol.
, vol.19
, Issue.11
, pp. 502-508
-
-
Croft, S.L.1
Coombs, G.H.2
-
57
-
-
0037325060
-
Antiprotozoal activities of phospholipid analogues
-
Croft S.L., Seifert K., Duchene M. Antiprotozoal activities of phospholipid analogues. Mol. Biochem. Parasitol. 2003, 126(2):165-172.
-
(2003)
Mol. Biochem. Parasitol.
, vol.126
, Issue.2
, pp. 165-172
-
-
Croft, S.L.1
Seifert, K.2
Duchene, M.3
-
58
-
-
84859080629
-
Drug screen targeted at plasmodium liver stages identifies a potent multistage antimalarial drug
-
da Cruz F.P., Martin C., Buchholz K., Lafuente-Monasterio M.J., Rodrigues T., Sonnichsen B., Moreira R., Gamo F.J., Marti M., Mota M.M., Hannus M., Prudencio M. Drug screen targeted at plasmodium liver stages identifies a potent multistage antimalarial drug. J. Infect. Dis. 2012, 205(8):1278-1286.
-
(2012)
J. Infect. Dis.
, vol.205
, Issue.8
, pp. 1278-1286
-
-
da Cruz, F.P.1
Martin, C.2
Buchholz, K.3
Lafuente-Monasterio, M.J.4
Rodrigues, T.5
Sonnichsen, B.6
Moreira, R.7
Gamo, F.J.8
Marti, M.9
Mota, M.M.10
Hannus, M.11
Prudencio, M.12
-
59
-
-
0026515452
-
Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group
-
Dannemann B., McCutchan J.A., Israelski D., Antoniskis D., Leport C., Luft B., Nussbaum J., Clumeck N., Morlat P., Chiu J., et al. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group. Ann. Intern. Med. 1992, 116(1):33-43.
-
(1992)
Ann. Intern. Med.
, vol.116
, Issue.1
, pp. 33-43
-
-
Dannemann, B.1
McCutchan, J.A.2
Israelski, D.3
Antoniskis, D.4
Leport, C.5
Luft, B.6
Nussbaum, J.7
Clumeck, N.8
Morlat, P.9
Chiu, J.10
-
61
-
-
84858693360
-
Pharmacological validation of Trypanosoma brucei phosphodiesterases as novel drug targets
-
de Koning H.P., Gould M.K., Sterk G.J., Tenor H., Kunz S., Luginbuehl E., Seebeck T. Pharmacological validation of Trypanosoma brucei phosphodiesterases as novel drug targets. J. Infect. Dis. 2012, 206(2):229-237.
-
(2012)
J. Infect. Dis.
, vol.206
, Issue.2
, pp. 229-237
-
-
de Koning, H.P.1
Gould, M.K.2
Sterk, G.J.3
Tenor, H.4
Kunz, S.5
Luginbuehl, E.6
Seebeck, T.7
-
62
-
-
84862015314
-
A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target
-
Debnath A., Parsonage D., Andrade R.M., He C., Cobo E.R., Hirata K., Chen S., Garcia-Rivera G., Orozco E., Martinez M.B., Gunatilleke S.S., Barrios A.M., Arkin M.R., Poole L.B., McKerrow J.H., Reed S.L. A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target. Nat. Med. 2012, 18(6):956-960.
-
(2012)
Nat. Med.
, vol.18
, Issue.6
, pp. 956-960
-
-
Debnath, A.1
Parsonage, D.2
Andrade, R.M.3
He, C.4
Cobo, E.R.5
Hirata, K.6
Chen, S.7
Garcia-Rivera, G.8
Orozco, E.9
Martinez, M.B.10
Gunatilleke, S.S.11
Barrios, A.M.12
Arkin, M.R.13
Poole, L.B.14
McKerrow, J.H.15
Reed, S.L.16
-
63
-
-
84861904136
-
Liver-stage malaria parasites vulnerable to diverse chemical scaffolds
-
Derbyshire E.R., Prudencio M., Mota M.M., Clardy J. Liver-stage malaria parasites vulnerable to diverse chemical scaffolds. Proc. Natl. Acad. Sci. USA 2012, 109(22):8511-8516.
-
(2012)
Proc. Natl. Acad. Sci. USA
, vol.109
, Issue.22
, pp. 8511-8516
-
-
Derbyshire, E.R.1
Prudencio, M.2
Mota, M.M.3
Clardy, J.4
-
64
-
-
0023749458
-
Spiramycin: safety in man
-
Descotes J., Vial T., Delattre D., Evreux J.C. Spiramycin: safety in man. J. Antimicrob. Chemother. 1988, 22(Suppl. B):207-210.
-
(1988)
J. Antimicrob. Chemother.
, vol.22
, Issue.SUPPL. B
, pp. 207-210
-
-
Descotes, J.1
Vial, T.2
Delattre, D.3
Evreux, J.C.4
-
65
-
-
0016394869
-
Congenital toxoplasmosis. A prospective study of 378 pregnancies
-
Desmonts G., Couvreur J. Congenital toxoplasmosis. A prospective study of 378 pregnancies. N. Engl. J. Med. 1974, 290(20):1110-1116.
-
(1974)
N. Engl. J. Med.
, vol.290
, Issue.20
, pp. 1110-1116
-
-
Desmonts, G.1
Couvreur, J.2
-
66
-
-
0015962176
-
Toxoplasmosis in pregnancy and its transmission to the fetus
-
Desmonts G., Couvreur J. Toxoplasmosis in pregnancy and its transmission to the fetus. Bull. N.Y. Acad. Med. 1974, 50(2):146-159.
-
(1974)
Bull. N.Y. Acad. Med.
, vol.50
, Issue.2
, pp. 146-159
-
-
Desmonts, G.1
Couvreur, J.2
-
67
-
-
84884248924
-
Research perspective: potential role of nitazoxanide in ovarian cancer treatment. Old drug, new purpose?
-
Di Santo N., Ehrisman J. Research perspective: potential role of nitazoxanide in ovarian cancer treatment. Old drug, new purpose?. Cancers (Basel) 2013, 5(3):1163-1176.
-
(2013)
Cancers (Basel)
, vol.5
, Issue.3
, pp. 1163-1176
-
-
Di Santo, N.1
Ehrisman, J.2
-
68
-
-
0017231098
-
Single-dose therapy of Falciparum malaria using pyrimethamine in combination with diformyldapsone or sulfadoxine
-
Doberstyn E.B., Hall A.P., Vetvutanapibul K., Sonkon P. Single-dose therapy of Falciparum malaria using pyrimethamine in combination with diformyldapsone or sulfadoxine. Am. J. Trop. Med. Hyg. 1976, 25(1):14-19.
-
(1976)
Am. J. Trop. Med. Hyg.
, vol.25
, Issue.1
, pp. 14-19
-
-
Doberstyn, E.B.1
Hall, A.P.2
Vetvutanapibul, K.3
Sonkon, P.4
-
69
-
-
84880926027
-
Artemisinin resistance is a clear and present danger
-
Dondorp A.M., Ringwald P. Artemisinin resistance is a clear and present danger. Trends Parasitol. 2013, 29(8):359-360.
-
(2013)
Trends Parasitol.
, vol.29
, Issue.8
, pp. 359-360
-
-
Dondorp, A.M.1
Ringwald, P.2
-
70
-
-
68049123592
-
Artemisinin resistance in plasmodium falciparum malaria
-
Dondorp A.M., Nosten F., Yi P., Das D., Phyo A.P., Tarning J., Lwin K.M., Ariey F., Hanpithakpong W., Lee S.J., Ringwald P., Silamut K., Imwong M., Chotivanich K., Lim P., Herdman T., An S.S., Yeung S., Singhasivanon P., Day N.P.J., Lindegardh N., Socheat D., White N.J. Artemisinin resistance in plasmodium falciparum malaria. N. Engl. J. Med. 2009, 361(5):455-467.
-
(2009)
N. Engl. J. Med.
, vol.361
, Issue.5
, pp. 455-467
-
-
Dondorp, A.M.1
Nosten, F.2
Yi, P.3
Das, D.4
Phyo, A.P.5
Tarning, J.6
Lwin, K.M.7
Ariey, F.8
Hanpithakpong, W.9
Lee, S.J.10
Ringwald, P.11
Silamut, K.12
Imwong, M.13
Chotivanich, K.14
Lim, P.15
Herdman, T.16
An, S.S.17
Yeung, S.18
Singhasivanon, P.19
Day, N.P.J.20
Lindegardh, N.21
Socheat, D.22
White, N.J.23
more..
-
71
-
-
84867610036
-
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
-
Dorlo T.P., Balasegaram M., Beijnen J.H., de Vries P.J. Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. J. Antimicrob. Chemother. 2012, 67(11):2576-2597.
-
(2012)
J. Antimicrob. Chemother.
, vol.67
, Issue.11
, pp. 2576-2597
-
-
Dorlo, T.P.1
Balasegaram, M.2
Beijnen, J.H.3
de Vries, P.J.4
-
72
-
-
51549118662
-
The antiviral activities of artemisinin and artesunate
-
Efferth T., Romero M.R., Wolf D.G., Stamminger T., Marin J.J., Marschall M. The antiviral activities of artemisinin and artesunate. Clin. Infect. Dis. 2008, 47(6):804-811.
-
(2008)
Clin. Infect. Dis.
, vol.47
, Issue.6
, pp. 804-811
-
-
Efferth, T.1
Romero, M.R.2
Wolf, D.G.3
Stamminger, T.4
Marin, J.J.5
Marschall, M.6
-
73
-
-
34548304745
-
In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
-
Ekins S., Mestres J., Testa B. In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. Br. J. Pharmacol. 2007, 152(1):9-20.
-
(2007)
Br. J. Pharmacol.
, vol.152
, Issue.1
, pp. 9-20
-
-
Ekins, S.1
Mestres, J.2
Testa, B.3
-
74
-
-
70350125916
-
The anti-hepatitis C agent nitazoxanide induces phosphorylation of eukaryotic initiation factor 2alpha via protein kinase activated by double-stranded RNA activation
-
Elazar M., Liu M., McKenna S.A., Liu P., Gehrig E.A., Puglisi J.D., Rossignol J.F., Glenn J.S. The anti-hepatitis C agent nitazoxanide induces phosphorylation of eukaryotic initiation factor 2alpha via protein kinase activated by double-stranded RNA activation. Gastroenterology 2009, 137(5):1827-1835.
-
(2009)
Gastroenterology
, vol.137
, Issue.5
, pp. 1827-1835
-
-
Elazar, M.1
Liu, M.2
McKenna, S.A.3
Liu, P.4
Gehrig, E.A.5
Puglisi, J.D.6
Rossignol, J.F.7
Glenn, J.S.8
-
75
-
-
77955402138
-
Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease
-
Engel J.C., Ang K.K., Chen S., Arkin M.R., McKerrow J.H., Doyle P.S. Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease. Antimicrob. Agents Chemother. 2010, 54(8):3326-3334.
-
(2010)
Antimicrob. Agents Chemother.
, vol.54
, Issue.8
, pp. 3326-3334
-
-
Engel, J.C.1
Ang, K.K.2
Chen, S.3
Arkin, M.R.4
McKerrow, J.H.5
Doyle, P.S.6
-
76
-
-
84884239273
-
A c-Myc activation sensor-based high-throughput drug screening identifies an antineoplastic effect of nitazoxanide
-
Fan-Minogue H., Bodapati S., Solow-Cordero D., Fan A., Paulmurugan R., Massoud T.F., Felsher D.W., Gambhir S.S. A c-Myc activation sensor-based high-throughput drug screening identifies an antineoplastic effect of nitazoxanide. Mol. Cancer Ther. 2013, 12(9):1896-1905.
-
(2013)
Mol. Cancer Ther.
, vol.12
, Issue.9
, pp. 1896-1905
-
-
Fan-Minogue, H.1
Bodapati, S.2
Solow-Cordero, D.3
Fan, A.4
Paulmurugan, R.5
Massoud, T.F.6
Felsher, D.W.7
Gambhir, S.S.8
-
77
-
-
0026537075
-
Azithromycin for cerebral toxoplasmosis
-
Farthing C., Rendel M., Currie B., Seidlin M. Azithromycin for cerebral toxoplasmosis. Lancet 1992, 339(8790):437-438.
-
(1992)
Lancet
, vol.339
, Issue.8790
, pp. 437-438
-
-
Farthing, C.1
Rendel, M.2
Currie, B.3
Seidlin, M.4
-
78
-
-
2942620300
-
Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-control study
-
Flegr J., Havlicek J., Kodym P., Maly M., Smahel Z. Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-control study. BMC Infect. Dis. 2002, 2:11.
-
(2002)
BMC Infect. Dis.
, vol.2
, pp. 11
-
-
Flegr, J.1
Havlicek, J.2
Kodym, P.3
Maly, M.4
Smahel, Z.5
-
79
-
-
67649687838
-
Increased incidence of traffic accidents in Toxoplasma-infected military drivers and protective effect RhD molecule revealed by a large-scale prospective cohort study
-
Flegr J., Klose J., Novotna M., Berenreitterova M., Havlicek J. Increased incidence of traffic accidents in Toxoplasma-infected military drivers and protective effect RhD molecule revealed by a large-scale prospective cohort study. BMC Infect. Dis. 2009, 9:72.
-
(2009)
BMC Infect. Dis.
, vol.9
, pp. 72
-
-
Flegr, J.1
Klose, J.2
Novotna, M.3
Berenreitterova, M.4
Havlicek, J.5
-
80
-
-
0000240697
-
Mel B in the treatment of human trypanosomiasis
-
Friedheim E.A. Mel B in the treatment of human trypanosomiasis. Am. J. Trop. Med. Hyg. 1949, 29(2):173-180.
-
(1949)
Am. J. Trop. Med. Hyg.
, vol.29
, Issue.2
, pp. 173-180
-
-
Friedheim, E.A.1
-
81
-
-
77952704258
-
Thousands of chemical starting points for antimalarial lead identification
-
Gamo F.J., Sanz L.M., Vidal J., de Cozar C., Alvarez E., Lavandera J.L., Vanderwall D.E., Green D.V., Kumar V., Hasan S., Brown J.R., Peishoff C.E., Cardon L.R., Garcia-Bustos J.F. Thousands of chemical starting points for antimalarial lead identification. Nature 2010, 465(7296):305-310.
-
(2010)
Nature
, vol.465
, Issue.7296
, pp. 305-310
-
-
Gamo, F.J.1
Sanz, L.M.2
Vidal, J.3
de Cozar, C.4
Alvarez, E.5
Lavandera, J.L.6
Vanderwall, D.E.7
Green, D.V.8
Kumar, V.9
Hasan, S.10
Brown, J.R.11
Peishoff, C.E.12
Cardon, L.R.13
Garcia-Bustos, J.F.14
-
82
-
-
77953023715
-
Chagas disease in Spain, the United States and other non-endemic countries
-
Gascon J., Bern C., Pinazo M.J. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop. 2010, 115(1-2):22-27.
-
(2010)
Acta Trop.
, vol.115
, Issue.1-2
, pp. 22-27
-
-
Gascon, J.1
Bern, C.2
Pinazo, M.J.3
-
83
-
-
0028029323
-
Management of toxoplasmosis
-
Georgiev V.S. Management of toxoplasmosis. Drugs 1994, 48(2):179-188.
-
(1994)
Drugs
, vol.48
, Issue.2
, pp. 179-188
-
-
Georgiev, V.S.1
-
84
-
-
0018399276
-
Drug therapy reviews: trimethoprim-sulfamethoxazole
-
Gleckman R., Alvarez S., Joubert D.W. Drug therapy reviews: trimethoprim-sulfamethoxazole. Am. J. Hosp. Pharm. 1979, 36(7):893-906.
-
(1979)
Am. J. Hosp. Pharm.
, vol.36
, Issue.7
, pp. 893-906
-
-
Gleckman, R.1
Alvarez, S.2
Joubert, D.W.3
-
85
-
-
84884534575
-
Drug library screening against metronidazole-sensitive and metronidazole-resistant Trichomonas vaginalis isolates
-
Goodhew E.B., Secor W.E. Drug library screening against metronidazole-sensitive and metronidazole-resistant Trichomonas vaginalis isolates. Sex. Transm. Infect. 2013, 89(6):479-484.
-
(2013)
Sex. Transm. Infect.
, vol.89
, Issue.6
, pp. 479-484
-
-
Goodhew, E.B.1
Secor, W.E.2
-
86
-
-
57149107850
-
Traversal of human and animal trypanosomes across the blood-brain barrier
-
Grab D.J., Kennedy P.G. Traversal of human and animal trypanosomes across the blood-brain barrier. J. Neurovirol. 2008, 14(5):344-351.
-
(2008)
J. Neurovirol.
, vol.14
, Issue.5
, pp. 344-351
-
-
Grab, D.J.1
Kennedy, P.G.2
-
87
-
-
0028239207
-
Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The new England regional Toxoplasma working group
-
Guerina N.G., Hsu H.W., Meissner H.C., Maguire J.H., Lynfield R., Stechenberg B., Abroms I., Pasternack M.S., Hoff R., Eaton R.B., et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The new England regional Toxoplasma working group. N. Engl. J. Med. 1994, 330(26):1858-1863.
-
(1994)
N. Engl. J. Med.
, vol.330
, Issue.26
, pp. 1858-1863
-
-
Guerina, N.G.1
Hsu, H.W.2
Meissner, H.C.3
Maguire, J.H.4
Lynfield, R.5
Stechenberg, B.6
Abroms, I.7
Pasternack, M.S.8
Hoff, R.9
Eaton, R.B.10
-
88
-
-
0032709747
-
Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four-seven years later in a poor urban community in northeast Brazil
-
Guerrant D.I., Moore S.R., Lima A.A., Patrick P.D., Schorling J.B., Guerrant R.L. Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four-seven years later in a poor urban community in northeast Brazil. Am. J. Trop. Med. Hyg. 1999, 61(5):707-713.
-
(1999)
Am. J. Trop. Med. Hyg.
, vol.61
, Issue.5
, pp. 707-713
-
-
Guerrant, D.I.1
Moore, S.R.2
Lima, A.A.3
Patrick, P.D.4
Schorling, J.B.5
Guerrant, R.L.6
-
89
-
-
84880854710
-
A class of sulfonamides with strong inhibitory action against the alpha-carbonic anhydrase from Trypanosoma cruzi
-
Guzel-Akdemir O., Akdemir A., Pan P., Vermelho A.B., Parkkila S., Scozzafava A., Capasso C., Supuran C.T. A class of sulfonamides with strong inhibitory action against the alpha-carbonic anhydrase from Trypanosoma cruzi. J. Med. Chem. 2013.
-
(2013)
J. Med. Chem.
-
-
Guzel-Akdemir, O.1
Akdemir, A.2
Pan, P.3
Vermelho, A.B.4
Parkkila, S.5
Scozzafava, A.6
Capasso, C.7
Supuran, C.T.8
-
90
-
-
0035100870
-
Human dermal safety studies with eflornithine HCl 13.9% cream (Vaniqa), a novel treatment for excessive facial hair
-
Hickman J.G., Huber F., Palmisano M. Human dermal safety studies with eflornithine HCl 13.9% cream (Vaniqa), a novel treatment for excessive facial hair. Curr. Med. Res. Opin. 2001, 16(4):235-244.
-
(2001)
Curr. Med. Res. Opin.
, vol.16
, Issue.4
, pp. 235-244
-
-
Hickman, J.G.1
Huber, F.2
Palmisano, M.3
-
91
-
-
84857809426
-
Enlarging the "Audacious Goal": elimination of the world's high prevalence neglected tropical diseases
-
Hotez P. Enlarging the "Audacious Goal": elimination of the world's high prevalence neglected tropical diseases. Vaccine 2011, 29(Suppl. 4):D104-D110.
-
(2011)
Vaccine
, vol.29
, Issue.SUPPL. 4
-
-
Hotez, P.1
-
92
-
-
84870267029
-
G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map
-
Howes R.E., Piel F.B., Patil A.P., Nyangiri O.A., Gething P.W., Dewi M., Hogg M.M., Battle K.E., Padilla C.D., Baird J.K., Hay S.I. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2012, 9(11):e1001339.
-
(2012)
PLoS Med.
, vol.9
, Issue.11
-
-
Howes, R.E.1
Piel, F.B.2
Patil, A.P.3
Nyangiri, O.A.4
Gething, P.W.5
Dewi, M.6
Hogg, M.M.7
Battle, K.E.8
Padilla, C.D.9
Baird, J.K.10
Hay, S.I.11
-
93
-
-
0142179154
-
Identification of novel isoform-selective inhibitors within class I histone deacetylases
-
Hu E., Dul E., Sung C.M., Chen Z., Kirkpatrick R., Zhang G.F., Johanson K., Liu R., Lago A., Hofmann G., Macarron R., de los Frailes M., Perez P., Krawiec J., Winkler J., Jaye M. Identification of novel isoform-selective inhibitors within class I histone deacetylases. J. Pharmacol. Exp. Ther. 2003, 307(2):720-728.
-
(2003)
J. Pharmacol. Exp. Ther.
, vol.307
, Issue.2
, pp. 720-728
-
-
Hu, E.1
Dul, E.2
Sung, C.M.3
Chen, Z.4
Kirkpatrick, R.5
Zhang, G.F.6
Johanson, K.7
Liu, R.8
Lago, A.9
Hofmann, G.10
Macarron, R.11
de los Frailes, M.12
Perez, P.13
Krawiec, J.14
Winkler, J.15
Jaye, M.16
-
94
-
-
79955428497
-
The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics
-
80ps16
-
Huang R., Southall N., Wang Y., Yasgar A., Shinn P., Jadhav A., Nguyen D.T., Austin C.P. The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics. Sci. Transl. Med. 2011, 3(80):80ps16.
-
(2011)
Sci. Transl. Med.
, vol.3
, Issue.80
-
-
Huang, R.1
Southall, N.2
Wang, Y.3
Yasgar, A.4
Shinn, P.5
Jadhav, A.6
Nguyen, D.T.7
Austin, C.P.8
-
95
-
-
0030824384
-
Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to d,l-alpha-difluoromethylornithine
-
Iten M., Mett H., Evans A., Enyaru J.C., Brun R., Kaminsky R. Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to d,l-alpha-difluoromethylornithine. Antimicrob. Agents Chemother. 1997, 41(9):1922-1925.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, Issue.9
, pp. 1922-1925
-
-
Iten, M.1
Mett, H.2
Evans, A.3
Enyaru, J.C.4
Brun, R.5
Kaminsky, R.6
-
96
-
-
22244437571
-
The genome of the kinetoplastid parasite
-
Ivens A.C., Peacock C.S., Worthey E.A., Murphy L., Aggarwal G., Berriman M., Sisk E., Rajandream M.A., Adlem E., Aert R., Anupama A., Apostolou Z., Attipoe P., Bason N., Bauser C., Beck A., Beverley S.M., Bianchettin G., Borzym K., Bothe G., Bruschi C.V., Collins M., Cadag E., Ciarloni L., Clayton C., Coulson R.M., Cronin A., Cruz A.K., Davies R.M., De Gaudenzi J., Dobson D.E., Duesterhoeft A., Fazelina G., Fosker N., Frasch A.C., Fraser A., Fuchs M., Gabel C., Goble A., Goffeau A., Harris D., Hertz-Fowler C., Hilbert H., Horn D., Huang Y., Klages S., Knights A., Kube M., Larke N., Litvin L., Lord A., Louie T., Marra M., Masuy D., Matthews K., Michaeli S., Mottram J.C., Muller-Auer S., Munden H., Nelson S., Norbertczak H., Oliver K., O'Neil S., Pentony M., Pohl T.M., Price C., Purnelle B., Quail M.A., Rabbinowitsch E., Reinhardt R., Rieger M., Rinta J., Robben J., Robertson L., Ruiz J.C., Rutter S., Saunders D., Schafer M., Schein J., Schwartz D.C., Seeger K., Seyler A., Sharp S., Shin H., Sivam D., Squares R., Squares S., Tosato V., Vogt C., Volckaert G., Wambutt R., Warren T., Wedler H., Woodward J., Zhou S., Zimmermann W., Smith D.F., Blackwell J.M., Stuart K.D., Barrell B., Myler P.J. The genome of the kinetoplastid parasite. Leishmania Major Sci. 2005, 309(5733):436-442.
-
(2005)
Leishmania Major Sci.
, vol.309
, Issue.5733
, pp. 436-442
-
-
Ivens, A.C.1
Peacock, C.S.2
Worthey, E.A.3
Murphy, L.4
Aggarwal, G.5
Berriman, M.6
Sisk, E.7
Rajandream, M.A.8
Adlem, E.9
Aert, R.10
Anupama, A.11
Apostolou, Z.12
Attipoe, P.13
Bason, N.14
Bauser, C.15
Beck, A.16
Beverley, S.M.17
Bianchettin, G.18
Borzym, K.19
Bothe, G.20
Bruschi, C.V.21
Collins, M.22
Cadag, E.23
Ciarloni, L.24
Clayton, C.25
Coulson, R.M.26
Cronin, A.27
Cruz, A.K.28
Davies, R.M.29
De Gaudenzi, J.30
Dobson, D.E.31
Duesterhoeft, A.32
Fazelina, G.33
Fosker, N.34
Frasch, A.C.35
Fraser, A.36
Fuchs, M.37
Gabel, C.38
Goble, A.39
Goffeau, A.40
Harris, D.41
Hertz-Fowler, C.42
Hilbert, H.43
Horn, D.44
Huang, Y.45
Klages, S.46
Knights, A.47
Kube, M.48
Larke, N.49
Litvin, L.50
Lord, A.51
Louie, T.52
Marra, M.53
Masuy, D.54
Matthews, K.55
Michaeli, S.56
Mottram, J.C.57
Muller-Auer, S.58
Munden, H.59
Nelson, S.60
Norbertczak, H.61
Oliver, K.62
O'Neil, S.63
Pentony, M.64
Pohl, T.M.65
Price, C.66
Purnelle, B.67
Quail, M.A.68
Rabbinowitsch, E.69
Reinhardt, R.70
Rieger, M.71
Rinta, J.72
Robben, J.73
Robertson, L.74
Ruiz, J.C.75
Rutter, S.76
Saunders, D.77
Schafer, M.78
Schein, J.79
Schwartz, D.C.80
Seeger, K.81
Seyler, A.82
Sharp, S.83
Shin, H.84
Sivam, D.85
Squares, R.86
Squares, S.87
Tosato, V.88
Vogt, C.89
Volckaert, G.90
Wambutt, R.91
Warren, T.92
Wedler, H.93
Woodward, J.94
Zhou, S.95
Zimmermann, W.96
Smith, D.F.97
Blackwell, J.M.98
Stuart, K.D.99
more..
-
97
-
-
78349302742
-
Tolerance and safety of nifurtimox in patients with chronic chagas disease
-
Jackson Y., Alirol E., Getaz L., Wolff H., Combescure C., Chappuis F. Tolerance and safety of nifurtimox in patients with chronic chagas disease. Clin. Infect. Dis. 2010, 51(10):e69-e75.
-
(2010)
Clin. Infect. Dis.
, vol.51
, Issue.10
-
-
Jackson, Y.1
Alirol, E.2
Getaz, L.3
Wolff, H.4
Combescure, C.5
Chappuis, F.6
-
98
-
-
80053459547
-
Innovative partnerships for drug discovery against neglected diseases
-
Jakobsen P.H., Wang M.W., Nwaka S. Innovative partnerships for drug discovery against neglected diseases. PLoS Negl. Trop. Dis. 2011, 5(9):e1221.
-
(2011)
PLoS Negl. Trop. Dis.
, vol.5
, Issue.9
-
-
Jakobsen, P.H.1
Wang, M.W.2
Nwaka, S.3
-
99
-
-
84876759859
-
Whole-organism high-throughput screening against Trypanosoma brucei brucei
-
Jones A.J., Avery V.M. Whole-organism high-throughput screening against Trypanosoma brucei brucei. Expert Opin. Drug Discov. 2013, 8(5):495-507.
-
(2013)
Expert Opin. Drug Discov.
, vol.8
, Issue.5
, pp. 495-507
-
-
Jones, A.J.1
Avery, V.M.2
-
100
-
-
0029785787
-
Risk factors for Toxoplasma gondii infection in pregnancy. Results of a prospective case-control study in Norway
-
Kapperud G., Jenum P.A., Stray-Pedersen B., Melby K.K., Eskild A., Eng J. Risk factors for Toxoplasma gondii infection in pregnancy. Results of a prospective case-control study in Norway. Am. J. Epidemiol. 1996, 144(4):405-412.
-
(1996)
Am. J. Epidemiol.
, vol.144
, Issue.4
, pp. 405-412
-
-
Kapperud, G.1
Jenum, P.A.2
Stray-Pedersen, B.3
Melby, K.K.4
Eskild, A.5
Eng, J.6
-
101
-
-
84874263173
-
Lapatinib-binding protein kinases in the African trypanosome: identification of cellular targets for kinase-directed chemical scaffolds
-
Katiyar S., Kufareva I., Behera R., Thomas S.M., Ogata Y., Pollastri M., Abagyan R., Mensa-Wilmot K. Lapatinib-binding protein kinases in the African trypanosome: identification of cellular targets for kinase-directed chemical scaffolds. PLoS ONE 2013, 8(2):e56150.
-
(2013)
PLoS ONE
, vol.8
, Issue.2
-
-
Katiyar, S.1
Kufareva, I.2
Behera, R.3
Thomas, S.M.4
Ogata, Y.5
Pollastri, M.6
Abagyan, R.7
Mensa-Wilmot, K.8
-
102
-
-
84965088820
-
A study of experimental cutaneous leishmaniasis in white mice
-
Kellina O.I. A study of experimental cutaneous leishmaniasis in white mice. Med. Parazitol. (Mosk). 1961, 30:684-691.
-
(1961)
Med. Parazitol. (Mosk).
, vol.30
, pp. 684-691
-
-
Kellina, O.I.1
-
103
-
-
84857369836
-
Inhibitors of human histone deacetylase with potent activity against the African trypanosome Trypanosoma brucei
-
Kelly J.M., Taylor M.C., Horn D., Loza E., Kalvinsh I., Bjorkling F. Inhibitors of human histone deacetylase with potent activity against the African trypanosome Trypanosoma brucei. Bioorg. Med. Chem. Lett. 2012, 22(5):1886-1890.
-
(2012)
Bioorg. Med. Chem. Lett.
, vol.22
, Issue.5
, pp. 1886-1890
-
-
Kelly, J.M.1
Taylor, M.C.2
Horn, D.3
Loza, E.4
Kalvinsh, I.5
Bjorkling, F.6
-
104
-
-
51549108736
-
The continuing problem of human African trypanosomiasis (sleeping sickness)
-
Kennedy P.G. The continuing problem of human African trypanosomiasis (sleeping sickness). Ann. Neurol. 2008, 64(2):116-126.
-
(2008)
Ann. Neurol.
, vol.64
, Issue.2
, pp. 116-126
-
-
Kennedy, P.G.1
-
105
-
-
84872373862
-
Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)
-
Kennedy P.G. Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness). Lancet Neurol. 2013, 12(2):186-194.
-
(2013)
Lancet Neurol.
, vol.12
, Issue.2
, pp. 186-194
-
-
Kennedy, P.G.1
-
106
-
-
0021948029
-
Qinghaosu (artemisinin): an antimalarial drug from China
-
Klayman D.L. Qinghaosu (artemisinin): an antimalarial drug from China. Science 1985, 228(4703):1049-1055.
-
(1985)
Science
, vol.228
, Issue.4703
, pp. 1049-1055
-
-
Klayman, D.L.1
-
107
-
-
84880508179
-
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study
-
Kotloff K.L., Nataro J.P., Blackwelder W.C., Nasrin D., Farag T.H., Panchalingam S., Wu Y., Sow S.O., Sur D., Breiman R.F., Faruque A.S., Zaidi A.K., Saha D., Alonso P.L., Tamboura B., Sanogo D., Onwuchekwa U., Manna B., Ramamurthy T., Kanungo S., Ochieng J.B., Omore R., Oundo J.O., Hossain A., Das S.K., Ahmed S., Qureshi S., Quadri F., Adegbola R.A., Antonio M., Hossain M.J., Akinsola A., Mandomando I., Nhampossa T., Acacio S., Biswas K., O'Reilly C.E., Mintz E.D., Berkeley L.Y., Muhsen K., Sommerfelt H., Robins-Browne R.M., Levine M.M. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 2013, 382(9888):209-222.
-
(2013)
Lancet
, vol.382
, Issue.9888
, pp. 209-222
-
-
Kotloff, K.L.1
Nataro, J.P.2
Blackwelder, W.C.3
Nasrin, D.4
Farag, T.H.5
Panchalingam, S.6
Wu, Y.7
Sow, S.O.8
Sur, D.9
Breiman, R.F.10
Faruque, A.S.11
Zaidi, A.K.12
Saha, D.13
Alonso, P.L.14
Tamboura, B.15
Sanogo, D.16
Onwuchekwa, U.17
Manna, B.18
Ramamurthy, T.19
Kanungo, S.20
Ochieng, J.B.21
Omore, R.22
Oundo, J.O.23
Hossain, A.24
Das, S.K.25
Ahmed, S.26
Qureshi, S.27
Quadri, F.28
Adegbola, R.A.29
Antonio, M.30
Hossain, M.J.31
Akinsola, A.32
Mandomando, I.33
Nhampossa, T.34
Acacio, S.35
Biswas, K.36
O'Reilly, C.E.37
Mintz, E.D.38
Berkeley, L.Y.39
Muhsen, K.40
Sommerfelt, H.41
Robins-Browne, R.M.42
Levine, M.M.43
more..
-
108
-
-
52949112588
-
Artemisinins: their growing importance in medicine
-
Krishna S., Bustamante L., Haynes R.K., Staines H.M. Artemisinins: their growing importance in medicine. Trends Pharmacol. Sci. 2008, 29(10):520-527.
-
(2008)
Trends Pharmacol. Sci.
, vol.29
, Issue.10
, pp. 520-527
-
-
Krishna, S.1
Bustamante, L.2
Haynes, R.K.3
Staines, H.M.4
-
109
-
-
10444281634
-
Carbonic anhydrase inhibitors. Inhibition of Plasmodium falciparum carbonic anhydrase with aromatic sulfonamides: towards antimalarials with a novel mechanism of action?
-
Krungkrai J., Scozzafava A., Reungprapavut S., Krungkrai S.R., Rattanajak R., Kamchonwongpaisan S., Supuran C.T. Carbonic anhydrase inhibitors. Inhibition of Plasmodium falciparum carbonic anhydrase with aromatic sulfonamides: towards antimalarials with a novel mechanism of action?. Bioorg. Med. Chem. 2005, 13(2):483-489.
-
(2005)
Bioorg. Med. Chem.
, vol.13
, Issue.2
, pp. 483-489
-
-
Krungkrai, J.1
Scozzafava, A.2
Reungprapavut, S.3
Krungkrai, S.R.4
Rattanajak, R.5
Kamchonwongpaisan, S.6
Supuran, C.T.7
-
110
-
-
53549094659
-
Carbonic anhydrase inhibitors: inhibition of Plasmodium falciparum carbonic anhydrase with aromatic/heterocyclic sulfonamides-in vitro and in vivo studies
-
Krungkrai J., Krungkrai S.R., Supuran C.T. Carbonic anhydrase inhibitors: inhibition of Plasmodium falciparum carbonic anhydrase with aromatic/heterocyclic sulfonamides-in vitro and in vivo studies. Bioorg. Med. Chem. Lett. 2008, 18(20):5466-5471.
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, Issue.20
, pp. 5466-5471
-
-
Krungkrai, J.1
Krungkrai, S.R.2
Supuran, C.T.3
-
111
-
-
84875614866
-
Global economic burden of Chagas disease: a computational simulation model
-
Lee B.Y., Bacon K.M., Bottazzi M.E., Hotez P.J. Global economic burden of Chagas disease: a computational simulation model. Lancet Infect. Dis. 2013, 13(4):342-348.
-
(2013)
Lancet Infect. Dis.
, vol.13
, Issue.4
, pp. 342-348
-
-
Lee, B.Y.1
Bacon, K.M.2
Bottazzi, M.E.3
Hotez, P.J.4
-
112
-
-
0023934097
-
Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy
-
Leport C., Raffi F., Matheron S., Katlama C., Regnier B., Saimot A.G., Marche C., Vedrenne C., Vilde J.L. Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy. Am. J. Med. 1988, 84(1):94-100.
-
(1988)
Am. J. Med.
, vol.84
, Issue.1
, pp. 94-100
-
-
Leport, C.1
Raffi, F.2
Matheron, S.3
Katlama, C.4
Regnier, B.5
Saimot, A.G.6
Marche, C.7
Vedrenne, C.8
Vilde, J.L.9
-
113
-
-
0033509735
-
Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani
-
Lira R., Sundar S., Makharia A., Kenney R., Gam A., Saraiva E., Sacks D. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. J. Infect. Dis. 1999, 180(2):564-567.
-
(1999)
J. Infect. Dis.
, vol.180
, Issue.2
, pp. 564-567
-
-
Lira, R.1
Sundar, S.2
Makharia, A.3
Kenney, R.4
Gam, A.5
Saraiva, E.6
Sacks, D.7
-
114
-
-
84975019637
-
Studies in chemotherapy. XVI. The trypanocidal action of synthalin
-
Lourie E., Yorke W. Studies in chemotherapy. XVI. The trypanocidal action of synthalin. Ann. Trop. Med. Parasitol. 1937, 31:435-445.
-
(1937)
Ann. Trop. Med. Parasitol.
, vol.31
, pp. 435-445
-
-
Lourie, E.1
Yorke, W.2
-
115
-
-
84871036375
-
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
-
Lozano R., Naghavi M., Foreman K., Lim S., Shibuya K., Aboyans V., Abraham J., Adair T., Aggarwal R., Ahn S.Y., Alvarado M., Anderson H.R., Anderson L.M., Andrews K.G., Atkinson C., Baddour L.M., Barker-Collo S., Bartels D.H., Bell M.L., Benjamin E.J., Bennett D., Bhalla K., Bikbov B., Bin Abdulhak A., Birbeck G., Blyth F., Bolliger I., Boufous S., Bucello C., Burch M., Burney P., Carapetis J., Chen H., Chou D., Chugh S.S., Coffeng L.E., Colan S.D., Colquhoun S., Colson K.E., Condon J., Connor M.D., Cooper L.T., Corriere M., Cortinovis M., de Vaccaro K.C., Couser W., Cowie B.C., Criqui M.H., Cross M., Dabhadkar K.C., Dahodwala N., De Leo D., Degenhardt L., Delossantos A., Denenberg J., Des Jarlais D.C., Dharmaratne S.D., Dorsey E.R., Driscoll T., Duber H., Ebel B., Erwin P.J., Espindola P., Ezzati M., Feigin V., Flaxman A.D., Forouzanfar M.H., Fowkes F.G., Franklin R., Fransen M., Freeman M.K., Gabriel S.E., Gakidou E., Gaspari F., Gillum R.F., Gonzalez-Medina D., Halasa Y.A., Haring D., Harrison J.E., Havmoeller R., Hay R.J., Hoen B., Hotez P.J., Hoy D., Jacobsen K.H., James S.L., Jasrasaria R., Jayaraman S., Johns N., Karthikeyan G., Kassebaum N., Keren A., Khoo J.P., Knowlton L.M., Kobusingye O., Koranteng A., Krishnamurthi R., Lipnick M., Lipshultz S.E., Ohno S.L., Mabweijano J., MacIntyre M.F., Mallinger L., March L., Marks G.B., Marks R., Matsumori A., Matzopoulos R., Mayosi B.M., McAnulty J.H., McDermott M.M., McGrath J., Mensah G.A., Merriman T.R., Michaud C., Miller M., Miller T.R., Mock C., Mocumbi A.O., Mokdad A.A., Moran A., Mulholland K., Nair M.N., Naldi L., Narayan K.M., Nasseri K., Norman P., O'Donnell M., Omer S.B., Ortblad K., Osborne R., Ozgediz D., Pahari B., Pandian J.D., Rivero A.P., Padilla R.P., Perez-Ruiz F., Perico N., Phillips D., Pierce K., Pope C.A., Porrini E., Pourmalek F., Raju M., Ranganathan D., Rehm J.T., Rein D.B., Remuzzi G., Rivara F.P., Roberts T., De Leon F.R., Rosenfeld L.C., Rushton L., Sacco R.L., Salomon J.A., Sampson U., Sanman E., Schwebel D.C., Segui-Gomez M., Shepard D.S., Singh D., Singleton J., Sliwa K., Smith E., Steer A., Taylor J.A., Thomas B., Tleyjeh I.M., Towbin J.A., Truelsen T., Undurraga E.A., Venketasubramanian N., Vijayakumar L., Vos T., Wagner G.R., Wang M., Wang W., Watt K., Weinstock M.A., Weintraub R., Wilkinson J.D., Woolf A.D., Wulf S., Yeh P.H., Yip P., Zabetian A., Zheng Z.J., Lopez A.D., Murray C.J., AlMazroa M.A., Memish Z.A. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2095-2128.
-
(2012)
Lancet
, vol.380
, Issue.9859
, pp. 2095-2128
-
-
Lozano, R.1
Naghavi, M.2
Foreman, K.3
Lim, S.4
Shibuya, K.5
Aboyans, V.6
Abraham, J.7
Adair, T.8
Aggarwal, R.9
Ahn, S.Y.10
Alvarado, M.11
Anderson, H.R.12
Anderson, L.M.13
Andrews, K.G.14
Atkinson, C.15
Baddour, L.M.16
Barker-Collo, S.17
Bartels, D.H.18
Bell, M.L.19
Benjamin, E.J.20
Bennett, D.21
Bhalla, K.22
Bikbov, B.23
Bin Abdulhak, A.24
Birbeck, G.25
Blyth, F.26
Bolliger, I.27
Boufous, S.28
Bucello, C.29
Burch, M.30
Burney, P.31
Carapetis, J.32
Chen, H.33
Chou, D.34
Chugh, S.S.35
Coffeng, L.E.36
Colan, S.D.37
Colquhoun, S.38
Colson, K.E.39
Condon, J.40
Connor, M.D.41
Cooper, L.T.42
Corriere, M.43
Cortinovis, M.44
de Vaccaro, K.C.45
Couser, W.46
Cowie, B.C.47
Criqui, M.H.48
Cross, M.49
Dabhadkar, K.C.50
Dahodwala, N.51
De Leo, D.52
Degenhardt, L.53
Delossantos, A.54
Denenberg, J.55
Des Jarlais, D.C.56
Dharmaratne, S.D.57
Dorsey, E.R.58
Driscoll, T.59
Duber, H.60
Ebel, B.61
Erwin, P.J.62
Espindola, P.63
Ezzati, M.64
Feigin, V.65
Flaxman, A.D.66
Forouzanfar, M.H.67
Fowkes, F.G.68
Franklin, R.69
Fransen, M.70
Freeman, M.K.71
Gabriel, S.E.72
Gakidou, E.73
Gaspari, F.74
Gillum, R.F.75
Gonzalez-Medina, D.76
Halasa, Y.A.77
Haring, D.78
Harrison, J.E.79
Havmoeller, R.80
Hay, R.J.81
Hoen, B.82
Hotez, P.J.83
Hoy, D.84
Jacobsen, K.H.85
James, S.L.86
Jasrasaria, R.87
Jayaraman, S.88
Johns, N.89
Karthikeyan, G.90
Kassebaum, N.91
Keren, A.92
Khoo, J.P.93
Knowlton, L.M.94
Kobusingye, O.95
Koranteng, A.96
Krishnamurthi, R.97
Lipnick, M.98
Lipshultz, S.E.99
more..
-
116
-
-
84871041926
-
Plasmodium kinases as targets for new-generation antimalarials
-
Lucet I.S., Tobin A., Drewry D., Wilks A.F., Doerig C. Plasmodium kinases as targets for new-generation antimalarials. Future Med. Chem. 2012, 4(18):2295-2310.
-
(2012)
Future Med. Chem.
, vol.4
, Issue.18
, pp. 2295-2310
-
-
Lucet, I.S.1
Tobin, A.2
Drewry, D.3
Wilks, A.F.4
Doerig, C.5
-
117
-
-
0026901767
-
Toxoplasmic encephalitis in AIDS
-
Luft B.J., Remington J.S. Toxoplasmic encephalitis in AIDS. Clin. Infect. Dis. 1992, 15(2):211-222.
-
(1992)
Clin. Infect. Dis.
, vol.15
, Issue.2
, pp. 211-222
-
-
Luft, B.J.1
Remington, J.S.2
-
119
-
-
0031055981
-
Biochemical alterations in paromomycin-treated Leishmania donovani promastigotes
-
Maarouf M., Lawrence F., Brown S., Robert-Gero M. Biochemical alterations in paromomycin-treated Leishmania donovani promastigotes. Parasitol. Res. 1997, 83(2):198-202.
-
(1997)
Parasitol. Res.
, vol.83
, Issue.2
, pp. 198-202
-
-
Maarouf, M.1
Lawrence, F.2
Brown, S.3
Robert-Gero, M.4
-
120
-
-
33745199861
-
Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei
-
Mackey Z.B., Baca A.M., Mallari J.P., Apsel B., Shelat A., Hansell E.J., Chiang P.K., Wolff B., Guy K.R., Williams J., McKerrow J.H. Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei. Chem. Biol. Drug Des. 2006, 67(5):355-363.
-
(2006)
Chem. Biol. Drug Des.
, vol.67
, Issue.5
, pp. 355-363
-
-
Mackey, Z.B.1
Baca, A.M.2
Mallari, J.P.3
Apsel, B.4
Shelat, A.5
Hansell, E.J.6
Chiang, P.K.7
Wolff, B.8
Guy, K.R.9
Williams, J.10
McKerrow, J.H.11
-
121
-
-
84862208610
-
TDR Targets: a chemogenomics resource for neglected diseases
-
Magarinos M.P., Carmona S.J., Crowther G.J., Ralph S.A., Roos D.S., Shanmugam D., Van Voorhis W.C., Aguero F. TDR Targets: a chemogenomics resource for neglected diseases. Nucleic Acids Res. 2012, 40(Database issue):D1118-D1127.
-
(2012)
Nucleic Acids Res.
, vol.40
, Issue.DATABASE ISSUE
-
-
Magarinos, M.P.1
Carmona, S.J.2
Crowther, G.J.3
Ralph, S.A.4
Roos, D.S.5
Shanmugam, D.6
Van Voorhis, W.C.7
Aguero, F.8
-
122
-
-
84874304359
-
Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review
-
Manyando C., Njunju E.M., D'Alessandro U., Van Geertruyden J.P. Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review. PLoS ONE 2013, 8(2):e56916.
-
(2013)
PLoS ONE
, vol.8
, Issue.2
-
-
Manyando, C.1
Njunju, E.M.2
D'Alessandro, U.3
Van Geertruyden, J.P.4
-
123
-
-
0141960110
-
Identification and initial characterization of three novel cyclin-related proteins of the human malaria parasite Plasmodium falciparum
-
Merckx A., Le Roch K., Nivez M.P., Dorin D., Alano P., Gutierrez G.J., Nebreda A.R., Goldring D., Whittle C., Patterson S., Chakrabarti D., Doerig C. Identification and initial characterization of three novel cyclin-related proteins of the human malaria parasite Plasmodium falciparum. J. Biol. Chem. 2003, 278(41):39839-39850.
-
(2003)
J. Biol. Chem.
, vol.278
, Issue.41
, pp. 39839-39850
-
-
Merckx, A.1
Le Roch, K.2
Nivez, M.P.3
Dorin, D.4
Alano, P.5
Gutierrez, G.J.6
Nebreda, A.R.7
Goldring, D.8
Whittle, C.9
Patterson, S.10
Chakrabarti, D.11
Doerig, C.12
-
124
-
-
85015294644
-
Combination therapy with nitazoxanide and amphotericin B, Glucantime, miltefosine and sitamaquine against Leishmania (Leishmania) infantum intracellular amastigotes
-
Mesquita J.T., Tempone A.G., Reimao J.Q. Combination therapy with nitazoxanide and amphotericin B, Glucantime, miltefosine and sitamaquine against Leishmania (Leishmania) infantum intracellular amastigotes. Acta Trop. 2013.
-
(2013)
Acta Trop.
-
-
Mesquita, J.T.1
Tempone, A.G.2
Reimao, J.Q.3
-
125
-
-
0032991693
-
U.S. Food and Drug Administration approval of Am Bisome (liposomal amphotericin B) for treatment of visceral leishmaniasis
-
discussion 49-51
-
Meyerhoff A. U.S. Food and Drug Administration approval of Am Bisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. Clin. Infect. Dis. 1999, 28(1):42-48. discussion 49-51.
-
(1999)
Clin. Infect. Dis.
, vol.28
, Issue.1
, pp. 42-48
-
-
Meyerhoff, A.1
-
126
-
-
0016220150
-
Evaluation of clindamycin in combination with quinine against multidrug-resistant strains of Plasmodium falciparum
-
Miller L.H., Glew R.H., Wyler D.J., Howard W.A., Collins W.E., Contacos P.G., Neva F.A. Evaluation of clindamycin in combination with quinine against multidrug-resistant strains of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 1974, 23(4):565-569.
-
(1974)
Am. J. Trop. Med. Hyg.
, vol.23
, Issue.4
, pp. 565-569
-
-
Miller, L.H.1
Glew, R.H.2
Wyler, D.J.3
Howard, W.A.4
Collins, W.E.5
Contacos, P.G.6
Neva, F.A.7
-
127
-
-
34248369669
-
Artemisinins inhibit Trypanosoma cruzi and Trypanosoma brucei rhodesiense in vitro growth
-
Mishina Y.V., Krishna S., Haynes R.K., Meade J.C. Artemisinins inhibit Trypanosoma cruzi and Trypanosoma brucei rhodesiense in vitro growth. Antimicrob. Agents Chemother. 2007, 51(5):1852-1854.
-
(2007)
Antimicrob. Agents Chemother.
, vol.51
, Issue.5
, pp. 1852-1854
-
-
Mishina, Y.V.1
Krishna, S.2
Haynes, R.K.3
Meade, J.C.4
-
128
-
-
0021367819
-
Clinical trial of nifurtimox in human African trypanosomiasis
-
Moens F., De Wilde M., Ngato K. Clinical trial of nifurtimox in human African trypanosomiasis. Ann. Soc. Belg. Med. Trop. 1984, 64(1):37-43.
-
(1984)
Ann. Soc. Belg. Med. Trop.
, vol.64
, Issue.1
, pp. 37-43
-
-
Moens, F.1
De Wilde, M.2
Ngato, K.3
-
129
-
-
2942541583
-
-
Toxoplasmosis
-
Montoya J.G., Liesenfeld O. Toxoplasmosis. Lancet 2004, 363(9425):1965-1976.
-
(2004)
Lancet
, vol.363
, Issue.9425
, pp. 1965-1976
-
-
Montoya, J.G.1
Liesenfeld, O.2
-
130
-
-
79957918070
-
Could pharma open its drug freezers?
-
Mullard A. Could pharma open its drug freezers?. Nat. Rev. Drug Discov. 2011, 10(6):399-400.
-
(2011)
Nat. Rev. Drug Discov.
, vol.10
, Issue.6
, pp. 399-400
-
-
Mullard, A.1
-
131
-
-
84863204946
-
Drug repurposing programmes get lift off
-
Mullard A. Drug repurposing programmes get lift off. Nat. Rev. Drug Discov. 2012, 11(7):505-506.
-
(2012)
Nat. Rev. Drug Discov.
, vol.11
, Issue.7
, pp. 505-506
-
-
Mullard, A.1
-
132
-
-
37349023592
-
Neospora caninum: functional inhibition of protein disulfide isomerase by the broad-spectrum anti-parasitic drug nitazoxanide and other thiazolides
-
Muller J., Naguleswaran A., Muller N., Hemphill A. Neospora caninum: functional inhibition of protein disulfide isomerase by the broad-spectrum anti-parasitic drug nitazoxanide and other thiazolides. Exp. Parasitol. 2008, 118(1):80-88.
-
(2008)
Exp. Parasitol.
, vol.118
, Issue.1
, pp. 80-88
-
-
Muller, J.1
Naguleswaran, A.2
Muller, N.3
Hemphill, A.4
-
133
-
-
51949104566
-
Thiazolides inhibit growth and induce glutathione-S-transferase Pi (GSTP1)-dependent cell death in human colon cancer cells
-
Muller J., Sidler D., Nachbur U., Wastling J., Brunner T., Hemphill A. Thiazolides inhibit growth and induce glutathione-S-transferase Pi (GSTP1)-dependent cell death in human colon cancer cells. Int. J. Cancer 2008, 123(8):1797-1806.
-
(2008)
Int. J. Cancer
, vol.123
, Issue.8
, pp. 1797-1806
-
-
Muller, J.1
Sidler, D.2
Nachbur, U.3
Wastling, J.4
Brunner, T.5
Hemphill, A.6
-
134
-
-
84882331033
-
Evaluation of nifurtimox treatment of chronic chagas disease by means of several parasitological methods
-
Munoz C., Zulantay I., Apt W., Ortiz S., Schijman A.G., Bisio M., Ferrada V., Herrera C., Martinez G., Solari A. Evaluation of nifurtimox treatment of chronic chagas disease by means of several parasitological methods. Antimicrob. Agents Chemother. 2013, 57(9):4518-4523.
-
(2013)
Antimicrob. Agents Chemother.
, vol.57
, Issue.9
, pp. 4518-4523
-
-
Munoz, C.1
Zulantay, I.2
Apt, W.3
Ortiz, S.4
Schijman, A.G.5
Bisio, M.6
Ferrada, V.7
Herrera, C.8
Martinez, G.9
Solari, A.10
-
135
-
-
84883100343
-
Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment
-
Murphy G., Lisnevskaia L., Isenberg D. Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment. Lancet 2013, 382(9894):809-818.
-
(2013)
Lancet
, vol.382
, Issue.9894
, pp. 809-818
-
-
Murphy, G.1
Lisnevskaia, L.2
Isenberg, D.3
-
136
-
-
84856679687
-
Global malaria mortality between 1980 and 2010: a systematic analysis
-
Murray C.J., Rosenfeld L.C., Lim S.S., Andrews K.G., Foreman K.J., Haring D., Fullman N., Naghavi M., Lozano R., Lopez A.D. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 2012, 379(9814):413-431.
-
(2012)
Lancet
, vol.379
, Issue.9814
, pp. 413-431
-
-
Murray, C.J.1
Rosenfeld, L.C.2
Lim, S.S.3
Andrews, K.G.4
Foreman, K.J.5
Haring, D.6
Fullman, N.7
Naghavi, M.8
Lozano, R.9
Lopez, A.D.10
-
137
-
-
84871099014
-
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
-
Murray C.J., Vos T., Lozano R., Naghavi M., Flaxman A.D., Michaud C., Ezzati M., Shibuya K., Salomon J.A., Abdalla S., Aboyans V., Abraham J., Ackerman I., Aggarwal R., Ahn S.Y., Ali M.K., Alvarado M., Anderson H.R., Anderson L.M., Andrews K.G., Atkinson C., Baddour L.M., Bahalim A.N., Barker-Collo S., Barrero L.H., Bartels D.H., Basanez M.G., Baxter A., Bell M.L., Benjamin E.J., Bennett D., Bernabe E., Bhalla K., Bhandari B., Bikbov B., Bin Abdulhak A., Birbeck G., Black J.A., Blencowe H., Blore J.D., Blyth F., Bolliger I., Bonaventure A., Boufous S., Bourne R., Boussinesq M., Braithwaite T., Brayne C., Bridgett L., Brooker S., Brooks P., Brugha T.S., Bryan-Hancock C., Bucello C., Buchbinder R., Buckle G., Budke C.M., Burch M., Burney P., Burstein R., Calabria B., Campbell B., Canter C.E., Carabin H., Carapetis J., Carmona L., Cella C., Charlson F., Chen H., Cheng A.T., Chou D., Chugh S.S., Coffeng L.E., Colan S.D., Colquhoun S., Colson K.E., Condon J., Connor M.D., Cooper L.T., Corriere M., Cortinovis M., de Vaccaro K.C., Couser W., Cowie B.C., Criqui M.H., Cross M., Dabhadkar K.C., Dahiya M., Dahodwala N., Damsere-Derry J., Danaei G., Davis A., De Leo D., Degenhardt L., Dellavalle R., Delossantos A., Denenberg J., Derrett S., Des Jarlais D.C., Dharmaratne S.D., Dherani M., Diaz-Torne C., Dolk H., Dorsey E.R., Driscoll T., Duber H., Ebel B., Edmond K., Elbaz A., Ali S.E., Erskine H., Erwin P.J., Espindola P., Ewoigbokhan S.E., Farzadfar F., Feigin V., Felson D.T., Ferrari A., Ferri C.P., Fevre E.M., Finucane M.M., Flaxman S., Flood L., Foreman K., Forouzanfar M.H., Fowkes F.G., Fransen M., Freeman M.K., Gabbe B.J., Gabriel S.E., Gakidou E., Ganatra H.A., Garcia B., Gaspari F., Gillum R.F., Gmel G., Gonzalez-Medina D., Gosselin R., Grainger R., Grant B., Groeger J., Guillemin F., Gunnell D., Gupta R., Haagsma J., Hagan H., Halasa Y.A., Hall W., Haring D., Haro J.M., Harrison J.E., Havmoeller R., Hay R.J., Higashi H., Hill C., Hoen B., Hoffman H., Hotez P.J., Hoy D., Huang J.J., Ibeanusi S.E., Jacobsen K.H., James S.L., Jarvis D., Jasrasaria R., Jayaraman S., Johns N., Jonas J.B., Karthikeyan G., Kassebaum N., Kawakami N., Keren A., Khoo J.P., King C.H., Knowlton L.M., Kobusingye O., Koranteng A., Krishnamurthi R., Laden F., Lalloo R., Laslett L.L., Lathlean T., Leasher J.L., Lee Y.Y., Leigh J., Levinson D., Lim S.S., Limb E., Lin J.K., Lipnick M., Lipshultz S.E., Liu W., Loane M., Ohno S.L., Lyons R., Mabweijano J., MacIntyre M.F., Malekzadeh R., Mallinger L., Manivannan S., Marcenes W., March L., Margolis D.J., Marks G.B., Marks R., Matsumori A., Matzopoulos R., Mayosi B.M., McAnulty J.H., McDermott M.M., McGill N., McGrath J., Medina-Mora M.E., Meltzer M., Mensah G.A., Merriman T.R., Meyer A.C., Miglioli V., Miller M., Miller T.R., Mitchell P.B., Mock C., Mocumbi A.O., Moffitt T.E., Mokdad A.A., Monasta L., Montico M., Moradi-Lakeh M., Moran A., Morawska L., Mori R., Murdoch M.E., Mwaniki M.K., Naidoo K., Nair M.N., Naldi L., Narayan K.M., Nelson P.K., Nelson R.G., Nevitt M.C., Newton C.R., Nolte S., Norman P., Norman R., O'Donnell M., O'Hanlon S., Olives C., Omer S.B., Ortblad K., Osborne R., Ozgediz D., Page A., Pahari B., Pandian J.D., Rivero A.P., Patten S.B., Pearce N., Padilla R.P., Perez-Ruiz F., Perico N., Pesudovs K., Phillips D., Phillips M.R., Pierce K., Pion S., Polanczyk G.V., Polinder S., Pope C.A., Popova S., Porrini E., Pourmalek F., Prince M., Pullan R.L., Ramaiah K.D., Ranganathan D., Razavi H., Regan M., Rehm J.T., Rein D.B., Remuzzi G., Richardson K., Rivara F.P., Roberts T., Robinson C., De Leon F.R., Ronfani L., Room R., Rosenfeld L.C., Rushton L., Sacco R.L., Saha S., Sampson U., Sanchez-Riera L., Sanman E., Schwebel D.C., Scott J.G., Segui-Gomez M., Shahraz S., Shepard D.S., Shin H., Shivakoti R., Singh D., Singh G.M., Singh J.A., Singleton J., Sleet D.A., Sliwa K., Smith E., Smith J.L., Stapelberg N.J., Steer A., Steiner T., Stolk W.A., Stovner L.J., Sudfeld C., Syed S., Tamburlini G., Tavakkoli M., Taylor H.R., Taylor J.A., Taylor W.J., Thomas B., Thomson W.M., Thurston G.D., Tleyjeh I.M., Tonelli M., Towbin J.A., Truelsen T., Tsilimbaris M.K., Ubeda C., Undurraga E.A., van der Werf M.J., van Os J., Vavilala M.S., Venketasubramanian N., Wang M., Wang W., Watt K., Weatherall D.J., Weinstock M.A., Weintraub R., Weisskopf M.G., Weissman M.M., White R.A., Whiteford H., Wiebe N., Wiersma S.T., Wilkinson J.D., Williams H.C., Williams S.R., Witt E., Wolfe F., Woolf A.D., Wulf S., Yeh P.H., Zaidi A.K., Zheng Z.J., Zonies D., Lopez A.D., AlMazroa M.A., Memish Z.A. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2197-2223.
-
(2012)
Lancet
, vol.380
, Issue.9859
, pp. 2197-2223
-
-
Murray, C.J.1
Vos, T.2
Lozano, R.3
Naghavi, M.4
Flaxman, A.D.5
Michaud, C.6
Ezzati, M.7
Shibuya, K.8
Salomon, J.A.9
Abdalla, S.10
Aboyans, V.11
Abraham, J.12
Ackerman, I.13
Aggarwal, R.14
Ahn, S.Y.15
Ali, M.K.16
Alvarado, M.17
Anderson, H.R.18
Anderson, L.M.19
Andrews, K.G.20
Atkinson, C.21
Baddour, L.M.22
Bahalim, A.N.23
Barker-Collo, S.24
Barrero, L.H.25
Bartels, D.H.26
Basanez, M.G.27
Baxter, A.28
Bell, M.L.29
Benjamin, E.J.30
Bennett, D.31
Bernabe, E.32
Bhalla, K.33
Bhandari, B.34
Bikbov, B.35
Bin Abdulhak, A.36
Birbeck, G.37
Black, J.A.38
Blencowe, H.39
Blore, J.D.40
Blyth, F.41
Bolliger, I.42
Bonaventure, A.43
Boufous, S.44
Bourne, R.45
Boussinesq, M.46
Braithwaite, T.47
Brayne, C.48
Bridgett, L.49
Brooker, S.50
Brooks, P.51
Brugha, T.S.52
Bryan-Hancock, C.53
Bucello, C.54
Buchbinder, R.55
Buckle, G.56
Budke, C.M.57
Burch, M.58
Burney, P.59
Burstein, R.60
Calabria, B.61
Campbell, B.62
Canter, C.E.63
Carabin, H.64
Carapetis, J.65
Carmona, L.66
Cella, C.67
Charlson, F.68
Chen, H.69
Cheng, A.T.70
Chou, D.71
Chugh, S.S.72
Coffeng, L.E.73
Colan, S.D.74
Colquhoun, S.75
Colson, K.E.76
Condon, J.77
Connor, M.D.78
Cooper, L.T.79
Corriere, M.80
Cortinovis, M.81
de Vaccaro, K.C.82
Couser, W.83
Cowie, B.C.84
Criqui, M.H.85
Cross, M.86
Dabhadkar, K.C.87
Dahiya, M.88
Dahodwala, N.89
Damsere-Derry, J.90
Danaei, G.91
Davis, A.92
De Leo, D.93
Degenhardt, L.94
Dellavalle, R.95
Delossantos, A.96
Denenberg, J.97
Derrett, S.98
Des Jarlais, D.C.99
more..
-
138
-
-
17344379918
-
Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox
-
Murta S.M., Gazzinelli R.T., Brener Z., Romanha A.J. Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox. Mol. Biochem. Parasitol. 1998, 93(2):203-214.
-
(1998)
Mol. Biochem. Parasitol.
, vol.93
, Issue.2
, pp. 203-214
-
-
Murta, S.M.1
Gazzinelli, R.T.2
Brener, Z.3
Romanha, A.J.4
-
140
-
-
0026542263
-
Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala
-
Navin T.R., Arana B.A., Arana F.E., Berman J.D., Chajon J.F. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J. Infect. Dis. 1992, 165(3):528-534.
-
(1992)
J. Infect. Dis.
, vol.165
, Issue.3
, pp. 528-534
-
-
Navin, T.R.1
Arana, B.A.2
Arana, F.E.3
Berman, J.D.4
Chajon, J.F.5
-
141
-
-
0014256575
-
The effect of antibiotics of the neomycin group on experimental cutaneous leishmaniasis
-
Neal R.A. The effect of antibiotics of the neomycin group on experimental cutaneous leishmaniasis. Ann. Trop. Med. Parasitol. 1968, 62(1):54-62.
-
(1968)
Ann. Trop. Med. Parasitol.
, vol.62
, Issue.1
, pp. 54-62
-
-
Neal, R.A.1
-
142
-
-
0029060753
-
The sensitivity of Leishmania species to aminosidine
-
Neal R.A., Allen S., McCoy N., Olliaro P., Croft S.L. The sensitivity of Leishmania species to aminosidine. J. Antimicrob. Chemother. 1995, 35(5):577-584.
-
(1995)
J. Antimicrob. Chemother.
, vol.35
, Issue.5
, pp. 577-584
-
-
Neal, R.A.1
Allen, S.2
McCoy, N.3
Olliaro, P.4
Croft, S.L.5
-
143
-
-
33749441465
-
Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine protease
-
Nikolskaia O.V., de A.L.A.P., Kim Y.V., Lonsdale-Eccles J.D., Fukuma T., Scharfstein J., Grab D.J. Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine protease. J. Clin. Invest. 2006, 116(10):2739-2747.
-
(2006)
J. Clin. Invest.
, vol.116
, Issue.10
, pp. 2739-2747
-
-
Nikolskaia, O.V.1
de, A.L.A.P.2
Kim, Y.V.3
Lonsdale-Eccles, J.D.4
Fukuma, T.5
Scharfstein, J.6
Grab, D.J.7
-
144
-
-
84866643099
-
Artemisinin derivatives: a patent review (2006 - present)
-
Njuguna N.M., Ongarora D.S., Chibale K. Artemisinin derivatives: a patent review (2006 - present). Expert Opin. Ther. Pat. 2012, 22(10):1179-1203.
-
(2012)
Expert Opin. Ther. Pat.
, vol.22
, Issue.10
, pp. 1179-1203
-
-
Njuguna, N.M.1
Ongarora, D.S.2
Chibale, K.3
-
145
-
-
84882785178
-
Chagas disease: an overview of clinical and epidemiological aspects
-
Council on Chagas Disease of the Interamerican Society of Cardiology
-
Nunes M.C., Dones W., Morillo C.A., Encina J.J., Ribeiro A.L., Council on Chagas Disease of the Interamerican Society of Cardiology Chagas disease: an overview of clinical and epidemiological aspects. J. Am. Coll. Cardiol. 2013, 62(9):767-776.
-
(2013)
J. Am. Coll. Cardiol.
, vol.62
, Issue.9
, pp. 767-776
-
-
Nunes, M.C.1
Dones, W.2
Morillo, C.A.3
Encina, J.J.4
Ribeiro, A.L.5
-
146
-
-
33750531864
-
Innovative lead discovery strategies for tropical diseases
-
Nwaka S., Hudson A. Innovative lead discovery strategies for tropical diseases. Nat. Rev. Drug Discov. 2006, 5(11):941-955.
-
(2006)
Nat. Rev. Drug Discov.
, vol.5
, Issue.11
, pp. 941-955
-
-
Nwaka, S.1
Hudson, A.2
-
147
-
-
84888094480
-
Small molecule kinase inhibitors approved by the FDA from 2000 to 2011: a systematic review of preclinical ADME data
-
O'Brien Z., Fallah Moghaddam M. Small molecule kinase inhibitors approved by the FDA from 2000 to 2011: a systematic review of preclinical ADME data. Expert Opin. Drug Metab. Toxicol. 2013, 9(12):1597-1612.
-
(2013)
Expert Opin. Drug Metab. Toxicol.
, vol.9
, Issue.12
, pp. 1597-1612
-
-
O'Brien, Z.1
Fallah Moghaddam, M.2
-
148
-
-
84876033143
-
The human Aurora kinase inhibitor danusertib is a lead compound for anti-trypanosomal drug discovery via target repurposing
-
Ochiana S.O., Pandarinath V., Wang Z., Kapoor R., Ondrechen M.J., Ruben L., Pollastri M.P. The human Aurora kinase inhibitor danusertib is a lead compound for anti-trypanosomal drug discovery via target repurposing. Eur. J. Med. Chem. 2013, 62:777-784.
-
(2013)
Eur. J. Med. Chem.
, vol.62
, pp. 777-784
-
-
Ochiana, S.O.1
Pandarinath, V.2
Wang, Z.3
Kapoor, R.4
Ondrechen, M.J.5
Ruben, L.6
Pollastri, M.P.7
-
149
-
-
5644245285
-
Management of children with infection-associated persistent diarrhea
-
Ochoa T.J., Salazar-Lindo E., Cleary T.G. Management of children with infection-associated persistent diarrhea. Semin. Pediatr. Infect. Dis. 2004, 15(4):229-236.
-
(2004)
Semin. Pediatr. Infect. Dis.
, vol.15
, Issue.4
, pp. 229-236
-
-
Ochoa, T.J.1
Salazar-Lindo, E.2
Cleary, T.G.3
-
150
-
-
84874964102
-
Artemether and lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa
-
Ogutu B. Artemether and lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa. Expert Opin. Pharmacother. 2013, 14(5):643-654.
-
(2013)
Expert Opin. Pharmacother.
, vol.14
, Issue.5
, pp. 643-654
-
-
Ogutu, B.1
-
151
-
-
0043162130
-
Amphotericin B: time for a new "gold standard"
-
Ostrosky-Zeichner L., Marr K.A., Rex J.H., Cohen S.H. Amphotericin B: time for a new "gold standard". Clin. Infect. Dis. 2003, 37(3):415-425.
-
(2003)
Clin. Infect. Dis.
, vol.37
, Issue.3
, pp. 415-425
-
-
Ostrosky-Zeichner, L.1
Marr, K.A.2
Rex, J.H.3
Cohen, S.H.4
-
152
-
-
0030996657
-
A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey
-
Ozgoztasi O., Baydar I. A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey. Int. J. Dermatol. 1997, 36(1):61-63.
-
(1997)
Int. J. Dermatol.
, vol.36
, Issue.1
, pp. 61-63
-
-
Ozgoztasi, O.1
Baydar, I.2
-
153
-
-
84898010996
-
-
Paladin Labs Inc, Application for Inclusion of Miltefosine on WHO. Model List of Essential Medicines.
-
Paladin Labs Inc, 2010. Application for Inclusion of Miltefosine on WHO. Model List of Essential Medicines.
-
(2010)
-
-
-
154
-
-
35548984903
-
Meta-analysis of three case controlled studies and an ecological study into the link between cryptogenic epilepsy and chronic toxoplasmosis infection
-
Palmer B.S. Meta-analysis of three case controlled studies and an ecological study into the link between cryptogenic epilepsy and chronic toxoplasmosis infection. Seizure 2007, 16(8):657-663.
-
(2007)
Seizure
, vol.16
, Issue.8
, pp. 657-663
-
-
Palmer, B.S.1
-
155
-
-
84874592654
-
Cloning, characterization, and sulfonamide and thiol inhibition studies of an alpha-carbonic anhydrase from Trypanosoma cruzi, the causative agent of Chagas disease
-
Pan P., Vermelho A.B., Capaci Rodrigues G., Scozzafava A., Tolvanen M.E., Parkkila S., Capasso C., Supuran C.T. Cloning, characterization, and sulfonamide and thiol inhibition studies of an alpha-carbonic anhydrase from Trypanosoma cruzi, the causative agent of Chagas disease. J. Med. Chem. 2013, 56(4):1761-1771.
-
(2013)
J. Med. Chem.
, vol.56
, Issue.4
, pp. 1761-1771
-
-
Pan, P.1
Vermelho, A.B.2
Capaci Rodrigues, G.3
Scozzafava, A.4
Tolvanen, M.E.5
Parkkila, S.6
Capasso, C.7
Supuran, C.T.8
-
156
-
-
84878042492
-
Kinase scaffold repurposing for neglected disease drug discovery: discovery of an efficacious, lapatinib-derived lead compound for trypanosomiasis
-
Patel G., Karver C.E., Behera R., Guyett P.J., Sullenberger C., Edwards P., Roncal N.E., Mensa-Wilmot K., Pollastri M.P. Kinase scaffold repurposing for neglected disease drug discovery: discovery of an efficacious, lapatinib-derived lead compound for trypanosomiasis. J. Med. Chem. 2013, 56(10):3820-3832.
-
(2013)
J. Med. Chem.
, vol.56
, Issue.10
, pp. 3820-3832
-
-
Patel, G.1
Karver, C.E.2
Behera, R.3
Guyett, P.J.4
Sullenberger, C.5
Edwards, P.6
Roncal, N.E.7
Mensa-Wilmot, K.8
Pollastri, M.P.9
-
157
-
-
0026574444
-
Eflornithine treatment of refractory Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome
-
Paulson Y.J., Gilman T.M., Heseltine P.N., Sharma O.P., Boylen C.T. Eflornithine treatment of refractory Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Chest 1992, 101(1):67-74.
-
(1992)
Chest
, vol.101
, Issue.1
, pp. 67-74
-
-
Paulson, Y.J.1
Gilman, T.M.2
Heseltine, P.N.3
Sharma, O.P.4
Boylen, C.T.5
-
158
-
-
34347339518
-
Comparative genomic analysis of three Leishmania species that cause diverse human disease
-
Peacock C.S., Seeger K., Harris D., Murphy L., Ruiz J.C., Quail M.A., Peters N., Adlem E., Tivey A., Aslett M., Kerhornou A., Ivens A., Fraser A., Rajandream M.A., Carver T., Norbertczak H., Chillingworth T., Hance Z., Jagels K., Moule S., Ormond D., Rutter S., Squares R., Whitehead S., Rabbinowitsch E., Arrowsmith C., White B., Thurston S., Bringaud F., Baldauf S.L., Faulconbridge A., Jeffares D., Depledge D.P., Oyola S.O., Hilley J.D., Brito L.O., Tosi L.R., Barrell B., Cruz A.K., Mottram J.C., Smith D.F., Berriman M. Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat. Genet. 2007, 39(7):839-847.
-
(2007)
Nat. Genet.
, vol.39
, Issue.7
, pp. 839-847
-
-
Peacock, C.S.1
Seeger, K.2
Harris, D.3
Murphy, L.4
Ruiz, J.C.5
Quail, M.A.6
Peters, N.7
Adlem, E.8
Tivey, A.9
Aslett, M.10
Kerhornou, A.11
Ivens, A.12
Fraser, A.13
Rajandream, M.A.14
Carver, T.15
Norbertczak, H.16
Chillingworth, T.17
Hance, Z.18
Jagels, K.19
Moule, S.20
Ormond, D.21
Rutter, S.22
Squares, R.23
Whitehead, S.24
Rabbinowitsch, E.25
Arrowsmith, C.26
White, B.27
Thurston, S.28
Bringaud, F.29
Baldauf, S.L.30
Faulconbridge, A.31
Jeffares, D.32
Depledge, D.P.33
Oyola, S.O.34
Hilley, J.D.35
Brito, L.O.36
Tosi, L.R.37
Barrell, B.38
Cruz, A.K.39
Mottram, J.C.40
Smith, D.F.41
Berriman, M.42
more..
-
159
-
-
0028366196
-
The treatment of human African trypanosomiasis
-
Pepin J., Milord F. The treatment of human African trypanosomiasis. Adv. Parasitol. 1994, 33:1-47.
-
(1994)
Adv. Parasitol.
, vol.33
, pp. 1-47
-
-
Pepin, J.1
Milord, F.2
-
160
-
-
0023659828
-
Difluoromethylornithine for arseno-resistant Trypanosoma brucei gambiense sleeping sickness
-
Pepin J., Milord F., Guern C., Schechter P.J. Difluoromethylornithine for arseno-resistant Trypanosoma brucei gambiense sleeping sickness. Lancet 1987, 2(8573):1431-1433.
-
(1987)
Lancet
, vol.2
, Issue.8573
, pp. 1431-1433
-
-
Pepin, J.1
Milord, F.2
Guern, C.3
Schechter, P.J.4
-
161
-
-
26044468809
-
Opportunities and challenges in antiparasitic drug discovery
-
Pink R., Hudson A., Mouries M.A., Bendig M. Opportunities and challenges in antiparasitic drug discovery. Nat. Rev. Drug Discov. 2005, 4(9):727-740.
-
(2005)
Nat. Rev. Drug Discov.
, vol.4
, Issue.9
, pp. 727-740
-
-
Pink, R.1
Hudson, A.2
Mouries, M.A.3
Bendig, M.4
-
162
-
-
84878328364
-
Clinical follow-up of responses to treatment with benznidazol in Amazon: a cohort study of acute Chagas disease
-
Pinto A.Y., Valente Vda C., Coura J.R., Valente S.A., Junqueira A.C., Santos L.C., Ferreira A.G., de Macedo R.C. Clinical follow-up of responses to treatment with benznidazol in Amazon: a cohort study of acute Chagas disease. PLoS ONE 2013, 8(5):e64450.
-
(2013)
PLoS ONE
, vol.8
, Issue.5
-
-
Pinto, A.Y.1
Valente Vda, C.2
Coura, J.R.3
Valente, S.A.4
Junqueira, A.C.5
Santos, L.C.6
Ferreira, A.G.7
de Macedo, R.C.8
-
163
-
-
84867915028
-
In vitro antileishmanial drug susceptibility of clinical isolates from patients with Indian visceral leishmaniasis-status of newly introduced drugs
-
Prajapati V.K., Mehrotra S., Gautam S., Rai M., Sundar S. In vitro antileishmanial drug susceptibility of clinical isolates from patients with Indian visceral leishmaniasis-status of newly introduced drugs. Am. J. Trop. Med. Hyg. 2012, 87(4):655-657.
-
(2012)
Am. J. Trop. Med. Hyg.
, vol.87
, Issue.4
, pp. 655-657
-
-
Prajapati, V.K.1
Mehrotra, S.2
Gautam, S.3
Rai, M.4
Sundar, S.5
-
164
-
-
38449084743
-
Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo
-
Priotto G., Kasparian S., Ngouama D., Ghorashian S., Arnold U., Ghabri S., Karunakara U. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo. Clin. Infect. Dis. 2007, 45(11):1435-1442.
-
(2007)
Clin. Infect. Dis.
, vol.45
, Issue.11
, pp. 1435-1442
-
-
Priotto, G.1
Kasparian, S.2
Ngouama, D.3
Ghorashian, S.4
Arnold, U.5
Ghabri, S.6
Karunakara, U.7
-
165
-
-
67649635323
-
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial
-
Priotto G., Kasparian S., Mutombo W., Ngouama D., Ghorashian S., Arnold U., Ghabri S., Baudin E., Buard V., Kazadi-Kyanza S., Ilunga M., Mutangala W., Pohlig G., Schmid C., Karunakara U., Torreele E., Kande V. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial. Lancet 2009, 374(9683):56-64.
-
(2009)
Lancet
, vol.374
, Issue.9683
, pp. 56-64
-
-
Priotto, G.1
Kasparian, S.2
Mutombo, W.3
Ngouama, D.4
Ghorashian, S.5
Arnold, U.6
Ghabri, S.7
Baudin, E.8
Buard, V.9
Kazadi-Kyanza, S.10
Ilunga, M.11
Mutangala, W.12
Pohlig, G.13
Schmid, C.14
Karunakara, U.15
Torreele, E.16
Kande, V.17
-
166
-
-
0021745207
-
Incidence of anemia in leprosy patients treated with dapsone
-
Puavilai S., Chutha S., Polnikorn N., Timpatanapong P., Tasanapradit P., Charuwichitratana S., Boonthanom A., Wongwaisayawan H. Incidence of anemia in leprosy patients treated with dapsone. J. Med. Assoc. Thai. 1984, 67(7):404-407.
-
(1984)
J. Med. Assoc. Thai.
, vol.67
, Issue.7
, pp. 404-407
-
-
Puavilai, S.1
Chutha, S.2
Polnikorn, N.3
Timpatanapong, P.4
Tasanapradit, P.5
Charuwichitratana, S.6
Boonthanom, A.7
Wongwaisayawan, H.8
-
167
-
-
3442888590
-
Plasmodium falciparum carbonic anhydrase is a possible target for malaria chemotherapy
-
Reungprapavut S., Krungkrai S.R., Krungkrai J. Plasmodium falciparum carbonic anhydrase is a possible target for malaria chemotherapy. J. Enzyme Inhib. Med. Chem. 2004, 19(3):249-256.
-
(2004)
J. Enzyme Inhib. Med. Chem.
, vol.19
, Issue.3
, pp. 249-256
-
-
Reungprapavut, S.1
Krungkrai, S.R.2
Krungkrai, J.3
-
168
-
-
0015149632
-
Effects of tetracycline against chloroquine-resistant and chloroquine-sensitive Plasmodium falciparum
-
Rieckmann K.H., Powell R.D., McNamara J.V., Willerson D., Lass L., Frischer H., Carson P.E. Effects of tetracycline against chloroquine-resistant and chloroquine-sensitive Plasmodium falciparum. Am. J. Trop. Med. Hyg. 1971, 20(6):811-815.
-
(1971)
Am. J. Trop. Med. Hyg.
, vol.20
, Issue.6
, pp. 811-815
-
-
Rieckmann, K.H.1
Powell, R.D.2
McNamara, J.V.3
Willerson, D.4
Lass, L.5
Frischer, H.6
Carson, P.E.7
-
169
-
-
4444244846
-
Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline
-
Rijal S., Chappuis F., Singh R., Bovier P.A., Acharya P., Karki B.M., Das M.L., Desjeux P., Loutan L., Koirala S. Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline. Trans. R. Soc. Trop. Med. Hyg. 2003, 97(3):350-354.
-
(2003)
Trans. R. Soc. Trop. Med. Hyg.
, vol.97
, Issue.3
, pp. 350-354
-
-
Rijal, S.1
Chappuis, F.2
Singh, R.3
Bovier, P.A.4
Acharya, P.5
Karki, B.M.6
Das, M.L.7
Desjeux, P.8
Loutan, L.9
Koirala, S.10
-
170
-
-
45249115279
-
High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo
-
Robays J., Nyamowala G., Sese C., Betu Ku., Mesu Kande V., Lutumba P., Van der Veken W., Boelaert M. High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo. Emerg. Infect. Dis. 2008, 14(6):966-967.
-
(2008)
Emerg. Infect. Dis.
, vol.14
, Issue.6
, pp. 966-967
-
-
Robays, J.1
Nyamowala, G.2
Sese, C.3
Betu, K.4
Mesu Kande, V.5
Lutumba, P.6
Van der Veken, W.7
Boelaert, M.8
-
171
-
-
84859523382
-
Epidemiology of and diagnostic strategies for toxoplasmosis
-
Robert-Gangneux F., Darde M.L. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin. Microbiol. Rev. 2012, 25(2):264-296.
-
(2012)
Clin. Microbiol. Rev.
, vol.25
, Issue.2
, pp. 264-296
-
-
Robert-Gangneux, F.1
Darde, M.L.2
-
172
-
-
84890861790
-
Synthesis and anti-plasmodium activity of benzimidazole analogues structurally related to astemizole
-
Roman G., Crandall I.E., Szarek W.A. Synthesis and anti-plasmodium activity of benzimidazole analogues structurally related to astemizole. ChemMedChem 2013.
-
(2013)
ChemMedChem
-
-
Roman, G.1
Crandall, I.E.2
Szarek, W.A.3
-
173
-
-
33645862564
-
Congenital toxoplasmosis-prenatal aspects of Toxoplasma gondii infection
-
Rorman E., Zamir C.S., Rilkis I., Ben-David H. Congenital toxoplasmosis-prenatal aspects of Toxoplasma gondii infection. Reprod. Toxicol. 2006, 21(4):458-472.
-
(2006)
Reprod. Toxicol.
, vol.21
, Issue.4
, pp. 458-472
-
-
Rorman, E.1
Zamir, C.S.2
Rilkis, I.3
Ben-David, H.4
-
175
-
-
33749571402
-
Antitumor activity of nifurtimox observed in a patient with neuroblastoma
-
Saulnier Sholler G.L., Kalkunte S., Greenlaw C., McCarten K., Forman E. Antitumor activity of nifurtimox observed in a patient with neuroblastoma. J. Pediatr. Hematol. Oncol. 2006, 28(10):693-695.
-
(2006)
J. Pediatr. Hematol. Oncol.
, vol.28
, Issue.10
, pp. 693-695
-
-
Saulnier Sholler, G.L.1
Kalkunte, S.2
Greenlaw, C.3
McCarten, K.4
Forman, E.5
-
176
-
-
78650775272
-
A phase 1 study of nifurtimox in patients with relapsed/refractory neuroblastoma
-
Saulnier Sholler G.L., Bergendahl G.M., Brard L., Singh A.P., Heath B.W., Bingham P.M., Ashikaga T., Kamen B.A., Homans A.C., Slavik M.A., Lenox S.R., Higgins T.J., Ferguson W.S. A phase 1 study of nifurtimox in patients with relapsed/refractory neuroblastoma. J. Pediatr. Hematol. Oncol. 2011, 33(1):25-30.
-
(2011)
J. Pediatr. Hematol. Oncol.
, vol.33
, Issue.1
, pp. 25-30
-
-
Saulnier Sholler, G.L.1
Bergendahl, G.M.2
Brard, L.3
Singh, A.P.4
Heath, B.W.5
Bingham, P.M.6
Ashikaga, T.7
Kamen, B.A.8
Homans, A.C.9
Slavik, M.A.10
Lenox, S.R.11
Higgins, T.J.12
Ferguson, W.S.13
-
177
-
-
10744225033
-
Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors
-
Savarino A., Lucia M.B., Rastrelli E., Rutella S., Golotta C., Morra E., Tamburrini E., Perno C.F., Boelaert J.R., Sperber K., Cauda R. Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors. J. Acquir. Immune Defic. Syndr. 2004, 35(3):223-232.
-
(2004)
J. Acquir. Immune Defic. Syndr.
, vol.35
, Issue.3
, pp. 223-232
-
-
Savarino, A.1
Lucia, M.B.2
Rastrelli, E.3
Rutella, S.4
Golotta, C.5
Morra, E.6
Tamburrini, E.7
Perno, C.F.8
Boelaert, J.R.9
Sperber, K.10
Cauda, R.11
-
178
-
-
70449267916
-
Treatment of amoebic hepatitis with emetine and chloroquine
-
Scaffidi V., Astuto R. Treatment of amoebic hepatitis with emetine and chloroquine. Panminerva Med. 1959, 1:162.
-
(1959)
Panminerva Med.
, vol.1
, pp. 162
-
-
Scaffidi, V.1
Astuto, R.2
-
179
-
-
77953024390
-
Efficacy of artemisinin in experimental visceral leishmaniasis
-
Sen R., Ganguly S., Saha P., Chatterjee M. Efficacy of artemisinin in experimental visceral leishmaniasis. Int. J. Antimicrob. Agents 2010, 36(1):43-49.
-
(2010)
Int. J. Antimicrob. Agents
, vol.36
, Issue.1
, pp. 43-49
-
-
Sen, R.1
Ganguly, S.2
Saha, P.3
Chatterjee, M.4
-
180
-
-
0035321503
-
Vaniqa-eflornithine 13.9% cream
-
5
-
Shapiro J., Lui H. Vaniqa-eflornithine 13.9% cream. Skin Therapy Lett. 2001, 6(7):1-3, 5.
-
(2001)
Skin Therapy Lett.
, vol.6
, Issue.7
, pp. 1-3
-
-
Shapiro, J.1
Lui, H.2
-
181
-
-
79952459914
-
The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: the way forward
-
Simarro P.P., Diarra A., Ruiz Postigo J.A., Franco J.R., Jannin J.G. The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: the way forward. PLoS Negl. Trop. Dis. 2011, 5(2):e1007.
-
(2011)
PLoS Negl. Trop. Dis.
, vol.5
, Issue.2
-
-
Simarro, P.P.1
Diarra, A.2
Ruiz Postigo, J.A.3
Franco, J.R.4
Jannin, J.G.5
-
182
-
-
84861909705
-
Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis
-
Simarro P.P., Franco J., Diarra A., Postigo J.A., Jannin J. Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis. Parasitology 2012, 139(7):842-846.
-
(2012)
Parasitology
, vol.139
, Issue.7
, pp. 842-846
-
-
Simarro, P.P.1
Franco, J.2
Diarra, A.3
Postigo, J.A.4
Jannin, J.5
-
183
-
-
0030662679
-
The efficacy of benzimidazole drugs against Plasmodium falciparum in vitro
-
Skinner-Adams T.S., Davis T.M., Manning L.S., Johnston W.A. The efficacy of benzimidazole drugs against Plasmodium falciparum in vitro. Trans. R. Soc. Trop. Med. Hyg. 1997, 91(5):580-584.
-
(1997)
Trans. R. Soc. Trop. Med. Hyg.
, vol.91
, Issue.5
, pp. 580-584
-
-
Skinner-Adams, T.S.1
Davis, T.M.2
Manning, L.S.3
Johnston, W.A.4
-
184
-
-
37849012349
-
The sulfonamide group as a structural alert: A distorted story?
-
Smith D.A., Jones R.M. The sulfonamide group as a structural alert: A distorted story?. Curr. Opin. Drug Discov. Devel. 2008, 11(1):72-79.
-
(2008)
Curr. Opin. Drug Discov. Devel.
, vol.11
, Issue.1
, pp. 72-79
-
-
Smith, D.A.1
Jones, R.M.2
-
185
-
-
0033638448
-
Phase II study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients
-
Smorenburg C.H., Seynaeve C., Bontenbal M., Planting A.S., Sindermann H., Verweij J. Phase II study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients. Anticancer Drugs 2000, 11(10):825-828.
-
(2000)
Anticancer Drugs
, vol.11
, Issue.10
, pp. 825-828
-
-
Smorenburg, C.H.1
Seynaeve, C.2
Bontenbal, M.3
Planting, A.S.4
Sindermann, H.5
Verweij, J.6
-
186
-
-
77952571195
-
Cryptosporidiosis in developing countries
-
Snelling W.J., Xiao L., Ortega-Pierres G., Lowery C.J., Moore J.E., Rao J.R., Smyth S., Millar B.C., Rooney P.J., Matsuda M., Kenny F., Xu J., Dooley J.S. Cryptosporidiosis in developing countries. J. Infect. Dev. Ctries. 2007, 1(3):242-256.
-
(2007)
J. Infect. Dev. Ctries.
, vol.1
, Issue.3
, pp. 242-256
-
-
Snelling, W.J.1
Xiao, L.2
Ortega-Pierres, G.3
Lowery, C.J.4
Moore, J.E.5
Rao, J.R.6
Smyth, S.7
Millar, B.C.8
Rooney, P.J.9
Matsuda, M.10
Kenny, F.11
Xu, J.12
Dooley, J.S.13
-
187
-
-
33645115547
-
Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial
-
Sotelo J., Briceno E., Lopez-Gonzalez M.A. Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 2006, 144(5):337-343.
-
(2006)
Ann. Intern. Med.
, vol.144
, Issue.5
, pp. 337-343
-
-
Sotelo, J.1
Briceno, E.2
Lopez-Gonzalez, M.A.3
-
188
-
-
77949441247
-
The development of drugs for treatment of sleeping sickness: a historical review
-
Steverding D. The development of drugs for treatment of sleeping sickness: a historical review. Parasit. Vectors 2010, 3(1):15.
-
(2010)
Parasit. Vectors
, vol.3
, Issue.1
, pp. 15
-
-
Steverding, D.1
-
189
-
-
0034780949
-
Drug resistance in Indian visceral leishmaniasis
-
Sundar S. Drug resistance in Indian visceral leishmaniasis. Trop. Med. Int. Health 2001, 6(11):849-854.
-
(2001)
Trop. Med. Int. Health
, vol.6
, Issue.11
, pp. 849-854
-
-
Sundar, S.1
-
190
-
-
78649980921
-
Liposomal amphotericin B and leishmaniasis: dose and response
-
Sundar S., Chakravarty J. Liposomal amphotericin B and leishmaniasis: dose and response. J. Global Infect. Dis. 2010, 2(2):159-166.
-
(2010)
J. Global Infect. Dis.
, vol.2
, Issue.2
, pp. 159-166
-
-
Sundar, S.1
Chakravarty, J.2
-
191
-
-
84871558204
-
Leishmaniasis: an update of current pharmacotherapy
-
Sundar S., Chakravarty J. Leishmaniasis: an update of current pharmacotherapy. Expert Opin. Pharmacother. 2013, 14(1):53-63.
-
(2013)
Expert Opin. Pharmacother.
, vol.14
, Issue.1
, pp. 53-63
-
-
Sundar, S.1
Chakravarty, J.2
-
192
-
-
0034451615
-
Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic
-
Sundar S., More D.K., Singh M.K., Singh V.P., Sharma S., Makharia A., Kumar P.C., Murray H.W. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin. Infect. Dis. 2000, 31(4):1104-1107.
-
(2000)
Clin. Infect. Dis.
, vol.31
, Issue.4
, pp. 1104-1107
-
-
Sundar, S.1
More, D.K.2
Singh, M.K.3
Singh, V.P.4
Sharma, S.5
Makharia, A.6
Kumar, P.C.7
Murray, H.W.8
-
193
-
-
42149158230
-
Carbonic anhydrases as drug targets
-
Supuran C.T. Carbonic anhydrases as drug targets. Curr. Pharm. Des. 2008, 14(7):601-602.
-
(2008)
Curr. Pharm. Des.
, vol.14
, Issue.7
, pp. 601-602
-
-
Supuran, C.T.1
-
194
-
-
38849143765
-
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
-
Supuran C.T. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat. Rev. Drug Discov. 2008, 7(2):168-181.
-
(2008)
Nat. Rev. Drug Discov.
, vol.7
, Issue.2
, pp. 168-181
-
-
Supuran, C.T.1
-
195
-
-
77954218410
-
Carbonic anhydrase inhibitors
-
Supuran C.T. Carbonic anhydrase inhibitors. Bioorg. Med. Chem. Lett. 2010, 20(12):3467-3474.
-
(2010)
Bioorg. Med. Chem. Lett.
, vol.20
, Issue.12
, pp. 3467-3474
-
-
Supuran, C.T.1
-
196
-
-
77951891892
-
Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally
-
Sutherland C.J., Tanomsing N., Nolder D., Oguike M., Jennison C., Pukrittayakamee S., Dolecek C., Hien T.T., do Rosario V.E., Arez A.P., Pinto J., Michon P., Escalante A.A., Nosten F., Burke M., Lee R., Blaze M., Otto T.D., Barnwell J.W., Pain A., Williams J., White N.J., Day N.P., Snounou G., Lockhart P.J., Chiodini P.L., Imwong M., Polley S.D. Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally. J. Infect. Dis. 2010, 201(10):1544-1550.
-
(2010)
J. Infect. Dis.
, vol.201
, Issue.10
, pp. 1544-1550
-
-
Sutherland, C.J.1
Tanomsing, N.2
Nolder, D.3
Oguike, M.4
Jennison, C.5
Pukrittayakamee, S.6
Dolecek, C.7
Hien, T.T.8
do Rosario, V.E.9
Arez, A.P.10
Pinto, J.11
Michon, P.12
Escalante, A.A.13
Nosten, F.14
Burke, M.15
Lee, R.16
Blaze, M.17
Otto, T.D.18
Barnwell, J.W.19
Pain, A.20
Williams, J.21
White, N.J.22
Day, N.P.23
Snounou, G.24
Lockhart, P.J.25
Chiodini, P.L.26
Imwong, M.27
Polley, S.D.28
more..
-
197
-
-
84884993499
-
Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Leishmania donovani chagasi, the protozoan parasite responsible for leishmaniasis
-
Syrjanen L., Vermelho A.B., de Almeida Rodrigues I., Corte-Real S., Salonen T., Pan P., Vullo D., Parkkila S., Capasso C., Supuran C.T. Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Leishmania donovani chagasi, the protozoan parasite responsible for leishmaniasis. J. Med. Chem. 2013, 56(18):7372-7381.
-
(2013)
J. Med. Chem.
, vol.56
, Issue.18
, pp. 7372-7381
-
-
Syrjanen, L.1
Vermelho, A.B.2
de Almeida Rodrigues, I.3
Corte-Real, S.4
Salonen, T.5
Pan, P.6
Vullo, D.7
Parkkila, S.8
Capasso, C.9
Supuran, C.T.10
-
198
-
-
79957998176
-
Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis
-
Centers for Disease C. and Prevention
-
Tan K.R., Magill A.J., Parise M.E., Arguin P.M., Centers for Disease C. and Prevention Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis. Am. J. Trop. Med. Hyg. 2011, 84(4):517-531.
-
(2011)
Am. J. Trop. Med. Hyg.
, vol.84
, Issue.4
, pp. 517-531
-
-
Tan, K.R.1
Magill, A.J.2
Parise, M.E.3
Arguin, P.M.4
-
199
-
-
24644446896
-
Open label extension studies: research or marketing?
-
Taylor G.J., Wainwright P. Open label extension studies: research or marketing?. BMJ 2005, 331(7516):572-574.
-
(2005)
BMJ
, vol.331
, Issue.7516
, pp. 572-574
-
-
Taylor, G.J.1
Wainwright, P.2
-
200
-
-
0032804471
-
Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases
-
Thakur C.P., Singh R.K., Hassan S.M., Kumar R., Narain S., Kumar A. Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases. Trans. R. Soc. Trop. Med. Hyg. 1999, 93(3):319-323.
-
(1999)
Trans. R. Soc. Trop. Med. Hyg.
, vol.93
, Issue.3
, pp. 319-323
-
-
Thakur, C.P.1
Singh, R.K.2
Hassan, S.M.3
Kumar, R.4
Narain, S.5
Kumar, A.6
-
201
-
-
84879575765
-
The global burden of congenital toxoplasmosis: a systematic review
-
Torgerson P.R., Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull. World Health Organ. 2013, 91(7):501-508.
-
(2013)
Bull. World Health Organ.
, vol.91
, Issue.7
, pp. 501-508
-
-
Torgerson, P.R.1
Mastroiacovo, P.2
-
202
-
-
34548032814
-
Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis
-
Torrey E.F., Bartko J.J., Lun Z.R., Yolken R.H. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr. Bull. 2007, 33(3):729-736.
-
(2007)
Schizophr. Bull.
, vol.33
, Issue.3
, pp. 729-736
-
-
Torrey, E.F.1
Bartko, J.J.2
Lun, Z.R.3
Yolken, R.H.4
-
203
-
-
0142227145
-
Specific chemotherapy of Chagas disease: controversies and advances
-
Urbina J.A., Docampo R. Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol. 2003, 19(11):495-501.
-
(2003)
Trends Parasitol.
, vol.19
, Issue.11
, pp. 495-501
-
-
Urbina, J.A.1
Docampo, R.2
-
204
-
-
0026793457
-
Advances in sleeping sickness therapy
-
Van Nieuwenhove S. Advances in sleeping sickness therapy. Ann. Soc. Belg. Med. Trop. 1992, 72(Suppl. 1):39-51.
-
(1992)
Ann. Soc. Belg. Med. Trop.
, vol.72
, Issue.SUPPL. 1
, pp. 39-51
-
-
Van Nieuwenhove, S.1
-
205
-
-
78951481408
-
A molecular mechanism for eflornithine resistance in African trypanosomes
-
Vincent I.M., Creek D., Watson D.G., Kamleh M.A., Woods D.J., Wong P.E., Burchmore R.J., Barrett M.P. A molecular mechanism for eflornithine resistance in African trypanosomes. PLoS Pathog. 2010, 6(11):e1001204.
-
(2010)
PLoS Pathog.
, vol.6
, Issue.11
-
-
Vincent, I.M.1
Creek, D.2
Watson, D.G.3
Kamleh, M.A.4
Woods, D.J.5
Wong, P.E.6
Burchmore, R.J.7
Barrett, M.P.8
-
206
-
-
78651321625
-
PROMISCUOUS: a database for network-based drug-repositioning
-
von Eichborn J., Murgueitio M.S., Dunkel M., Koerner S., Bourne P.E., Preissner R. PROMISCUOUS: a database for network-based drug-repositioning. Nucleic Acids Res. 2011, 39(Database issue):D1060-D1066.
-
(2011)
Nucleic Acids Res.
, vol.39
, Issue.DATABASE ISSUE
-
-
von Eichborn, J.1
Murgueitio, M.S.2
Dunkel, M.3
Koerner, S.4
Bourne, P.E.5
Preissner, R.6
-
207
-
-
84891805328
-
PubChem BioAssay: 2014 update
-
Wang Y., Suzek T., Zhang J., Wang J., He S., Cheng T., Shoemaker B.A., Gindulyte A., Bryant S.H. PubChem BioAssay: 2014 update. Nucleic Acids Res. 2014, 42(1):D1075-D1082.
-
(2014)
Nucleic Acids Res.
, vol.42
, Issue.1
-
-
Wang, Y.1
Suzek, T.2
Zhang, J.3
Wang, J.4
He, S.5
Cheng, T.6
Shoemaker, B.A.7
Gindulyte, A.8
Bryant, S.H.9
-
208
-
-
0015389380
-
Experience with nifurtimox in chronic Chagas' infection. Preliminary report
-
Wegner D.H., Rohwedder R.W. Experience with nifurtimox in chronic Chagas' infection. Preliminary report. Arzneimittelforschung 1972, 22(9):1635-1641.
-
(1972)
Arzneimittelforschung
, vol.22
, Issue.9
, pp. 1635-1641
-
-
Wegner, D.H.1
Rohwedder, R.W.2
-
209
-
-
33746169858
-
Searching for new antimalarial therapeutics amongst known drugs
-
Weisman J.L., Liou A.P., Shelat A.A., Cohen F.E., Guy R.K., DeRisi J.L. Searching for new antimalarial therapeutics amongst known drugs. Chem. Biol. Drug Des. 2006, 67(6):409-416.
-
(2006)
Chem. Biol. Drug Des.
, vol.67
, Issue.6
, pp. 409-416
-
-
Weisman, J.L.1
Liou, A.P.2
Shelat, A.A.3
Cohen, F.E.4
Guy, R.K.5
DeRisi, J.L.6
-
210
-
-
77956286255
-
Microbiology. Is the tide turning for new malaria medicines?
-
Wells T.N. Microbiology. Is the tide turning for new malaria medicines?. Science 2010, 329(5996):1153-1154.
-
(2010)
Science
, vol.329
, Issue.5996
, pp. 1153-1154
-
-
Wells, T.N.1
-
211
-
-
2942590820
-
Nitazoxanide: a new broad spectrum antiparasitic agent
-
White C.A. Nitazoxanide: a new broad spectrum antiparasitic agent. Expert Rev. Anti Infect. Ther. 2004, 2(1):43-49.
-
(2004)
Expert Rev. Anti Infect. Ther.
, vol.2
, Issue.1
, pp. 43-49
-
-
White, C.A.1
-
212
-
-
0009516038
-
Treatment of acute malaria with pyrimethamine
-
Wilson T., Edeson J.F. Treatment of acute malaria with pyrimethamine. Br. Med. J. 1953, 1(4804):253-255.
-
(1953)
Br. Med. J.
, vol.1
, Issue.4804
, pp. 253-255
-
-
Wilson, T.1
Edeson, J.F.2
-
213
-
-
0034775612
-
Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria
-
Winstanley P. Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria. Trop. Med. Int. Health 2001, 6(11):952-954.
-
(2001)
Trop. Med. Int. Health
, vol.6
, Issue.11
, pp. 952-954
-
-
Winstanley, P.1
-
214
-
-
38549151817
-
DrugBank: a knowledgebase for drugs, drug actions and drug targets
-
Wishart D.S., Knox C., Guo A.C., Cheng D., Shrivastava S., Tzur D., Gautam B., Hassanali M. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008, 36(Database issue):901-906.
-
(2008)
Nucleic Acids Res.
, vol.36
, Issue.DATABASE ISSUE
, pp. 901-906
-
-
Wishart, D.S.1
Knox, C.2
Guo, A.C.3
Cheng, D.4
Shrivastava, S.5
Tzur, D.6
Gautam, B.7
Hassanali, M.8
-
215
-
-
3242753439
-
-
Dapsone
-
Wolf R., Matz H., Orion E., Tuzun B., Tuzun Y. Dapsone. Dermatol. Online J. 2002, 8(1):2.
-
(2002)
Dermatol. Online J.
, vol.8
, Issue.1
, pp. 2
-
-
Wolf, R.1
Matz, H.2
Orion, E.3
Tuzun, B.4
Tuzun, Y.5
-
216
-
-
84897998551
-
-
World Health Organization, 2008. The global burden of disease: update.
-
World Health Organization, 2008. The global burden of disease: 2004 update.
-
-
-
-
217
-
-
84897976694
-
-
World Health Organization, Global report on antimalarial drug efficacy and drug resistance: 2000-2010.
-
World Health Organization 2010, Global report on antimalarial drug efficacy and drug resistance: 2000-2010.
-
(2010)
-
-
-
218
-
-
84898003209
-
-
World Health Organization, Chagas Disease: control and elimination. World Health Assembly Report.
-
World Health Organization, 2010a. Chagas Disease: control and elimination. World Health Assembly Report.
-
(2010)
-
-
-
219
-
-
84897981786
-
-
World Health Organization, Working to overcome the global impact of neglected tropical diseases. First WHO report on neglected tropical diseases.
-
World Health Organization, 2010b. Working to overcome the global impact of neglected tropical diseases. First WHO report on neglected tropical diseases.
-
(2010)
-
-
-
220
-
-
84897989957
-
-
World Health Organization, Global Health Observatory Map Gallery. Retrieved 15th November, from
-
World Health Organization, Global Health Observatory Map Gallery. Retrieved 15th November, 2013, from http://gamapserver.who.int/mapLibrary/.
-
(2013)
-
-
-
221
-
-
84897977671
-
-
World Health Organization, World Malaria Report 2013.
-
World Health Organization, 2013. World Malaria Report 2013.
-
(2013)
-
-
-
222
-
-
26844510687
-
Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins
-
Xiao S.H. Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins. Acta Trop. 2005, 96(2-3):153-167.
-
(2005)
Acta Trop.
, vol.96
, Issue.2-3
, pp. 153-167
-
-
Xiao, S.H.1
-
223
-
-
79961240592
-
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets
-
Yuan J., Cheng K.C., Johnson R.L., Huang R., Pattaradilokrat S., Liu A., Guha R., Fidock D.A., Inglese J., Wellems T.E., Austin C.P., Su X.Z. Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets. Science 2011, 333(6043):724-729.
-
(2011)
Science
, vol.333
, Issue.6043
, pp. 724-729
-
-
Yuan, J.1
Cheng, K.C.2
Johnson, R.L.3
Huang, R.4
Pattaradilokrat, S.5
Liu, A.6
Guha, R.7
Fidock, D.A.8
Inglese, J.9
Wellems, T.E.10
Austin, C.P.11
Su, X.Z.12
-
224
-
-
0025776247
-
Treatment of cutaneous sarcoidosis with chloroquine. Review of the literature
-
Zic J.A., Horowitz D.H., Arzubiaga C., King L.E. Treatment of cutaneous sarcoidosis with chloroquine. Review of the literature. Arch. Dermatol. 1991, 127(7):1034-1040.
-
(1991)
Arch. Dermatol.
, vol.127
, Issue.7
, pp. 1034-1040
-
-
Zic, J.A.1
Horowitz, D.H.2
Arzubiaga, C.3
King, L.E.4
|